Trading Analysis Report: QCOM¶

Analysis date: 2026-10-21
Rating: Underweight
Generated: 2026-10-21 11:15:55
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 178.28 Price As Of: 2026-10-21

QCOM (QUALCOMM Incorporated, NMS): Technical Analysis Report¶

0. Data integrity notes¶

Small discrepancy on the latest bar. The raw price pull shows a 2026-10-21 close of 178.29 and volume of 2,754,021. The verified snapshot shows 178.28 and 2,755,943. I used the snapshot, per the source-of-truth rule, and did not reconcile the two.
The 10-21 bar looks incomplete. Its volume of about 2.76M is far below the recent sessions, which ran roughly 6.8M to 12.5M in October. Treat the 10-21 close and the indicators that depend on it as provisional. That includes RSI, MACD, OBV and the z-score, and it applies to the "Price As Of" bar too.
Indicators I selected (8): close_50_sma, close_200_sma, supertrend, macd, rsi, atr, obv and z_score. The snapshot also supplied the 10 EMA, Bollinger bands, MACD signal and histogram, which I cite as snapshot values.
Not pulled: ADX and TD-9. I note below where that leaves a gap.

1. Big picture: what the last 12 months looked like¶

All figures below come from the price series. - Late 2025 to early 2026: the stock slid from the high 160s and 170s to a close of 134.20 on 2026-02-05. That day was a roughly 8.5% drop on about 30M shares. - Spring 2026: it bottomed at a closing low of 122.94 on 2026-04-07 (intraday low 120.88). - April 24 to May 29: a very sharp advance. It started with a gap from 132.73 to 147.50 on 2026-04-24 on about 29M shares. The highest close was 248.74 on 2026-05-29, and the intraday high was 257.56 that day. - June to July: a sustained, volatile decline. The close fell to 146.81 on 2026-07-31. - August to October: a recovery to a closing high of 201.97 on 2026-09-25, then a pullback. October closes have ranged from 172.11 to 184.87.

The stock is now about 28% below the May closing peak and about 45% above the April closing low. These are my own arithmetic on tool-reported closes. That leaves it in the middle of a large range, consolidating after a violent round trip.

2. Trend structure¶

Moving averages (snapshot)

Average	Value	Price vs. level
10 EMA	176.61	Price about 0.9% above
50 SMA	175.42	Price about 1.6% above
200 SMA	168.16	Price about 6.0% above

Stack: price (178.28) is above the 10 EMA (176.61), which is above the 50 SMA (175.42), which is above the 200 SMA (168.16). That is a constructive, bullish-ordered stack.
Slopes: the 50 SMA has risen steadily from 167.94 on 09-21 to 175.42 on 10-21. The 200 SMA is nearly flat but edging up, from 167.13 to 168.16 over the same window.
Compression: the three averages sit within about 8.5 points of each other, so the trend signal is weak. The gap between price and the 50 SMA is small.
One touch near the 200 SMA: the intraday low on 2026-10-15 was 168.84. That is just above the 200 SMA reading of 168.08 for that date. The tools show only this one instance, so it is not validated support.

SuperTrend (14, 3×ATR), the tiers disagree

Tier	Direction	Trailing stop	Close vs. stop
Weekly (primary)	DOWN	223.47	-20.22% (the stop is about 25% above the close)
Monthly (regime)	UP	116.42	+53.13%
Daily (timing)	DOWN	194.48	-8.33% (the stop is about 9.1% above the close)

Under the stated weighting rule (weekly > monthly > daily), the primary trend signal is down. The weekly line is anchored by the May–June peak area, so the post-peak correction has not been invalidated on that measure.
The monthly UP reading is regime context only. Its stop is 53% away, so it is not useful for risk sizing.
Flip levels: a daily close above 194.48 would flip the daily tier. The weekly tier would need a close above 223.47.
The averages and SuperTrend conflict. The MA stack is bullish, while the weekly and daily SuperTrend are bearish because price remains well below the post-rally highs.

3. Momentum¶

RSI is 50.00, dead neutral.
It was 67.96 on 09-25, the same day as the closing high of 201.97.
It dropped to 54.55 on 09-28 after a 7.2% one-day decline.
It has stayed in a 42.4–52.6 band throughout October.
It shows no overbought or oversold signal and no divergence in the data I have.
MACD is -1.24, signal -0.42, histogram -0.82.
MACD peaked at 8.12 on 09-25 and decayed steadily.
It crossed below zero on 10-13 (-0.25). It was +0.03 on 10-12.
It bottomed at -1.48 on 10-19 and has ticked up to -1.24.
It is still below its signal line, so there is no bullish crossover yet.
Read it as fading, not deeply bearish momentum. The values are small relative to a roughly 178 price, and the MACD line is hugging zero.
Net: momentum has rolled over from the late-September peak and is now neutral to mildly negative. A bullish MACD/signal cross would be a reasonable first sign of improvement. A move back toward the zero line would be a stronger one.

4. Volatility and range¶

ATR is 6.90, about 3.9% of price.
It has compressed from 9.12 on 09-28 to 6.90 now, so volatility is cooling inside the 30-day window.
It is still high for a large-cap semiconductor name. Daily ranges of 3–5% have been common in this data.
Bollinger bands:
Mid 180.56, upper 195.54, lower 165.58.
Price sits about 1.3% below the midline and at roughly 42% of the band width.
The bandwidth is about 16.6% of the midline.
No band-touch signal is present.
Stop-sizing reference, from ATR arithmetic only:
1.5×ATR is about 10.3 points, or about 168 from the current close.
2×ATR is about 13.8 points, or about 164.5.
These land near the 200 SMA (168.16) and the lower Bollinger band (165.58). That is a coincidence of levels, not a validated support zone.

5. Volume and participation¶

OBV is 555.7M.
It peaked in the 606–607M area on 09-22 and 09-25.
It fell to roughly 535M on 10-12 and 10-16, and it has since bounced.
Its decline since late September matches the price decline, so it confirms the pullback.
OBV and price made roughly equal lows around 10-12 and 10-16 (535.1M vs. 535.5M on OBV), with no clear divergence.
The 10-21 OBV uptick rests on a partial-volume bar, so confirmation is pending.
High-volume days to know about: 2026-09-18 saw a 5.8% drop on 54.5M shares. 2026-09-08 saw a gap up on 26.1M shares. The data does not say why.

6. Stretch and mean reversion (z-score, 20-period)¶

Timeframe	Z-score	Read
Weekly	-0.00	At the mean
Monthly	+0.58	Near the mean
Daily	-0.30	Near the mean

All three tiers are near fair value, so there is no statistical stretch to fade in either direction. This agrees with RSI at 50 and price sitting inside the Bollinger bands.

7. Synthesis and scenarios (observations, not a trade decision)¶

The indicators lean neutral and range-like. They give no clear directional edge.

Constructive evidence - Price is above the 10 EMA, 50 SMA and 200 SMA, and the 50 SMA is rising. - The monthly SuperTrend is UP. - There are no oversold or overbought extremes, and volatility is cooling. - OBV has bounced from its October lows.

Cautionary evidence - The weekly and daily SuperTrend are DOWN, and the weekly one is the highest-weighted signal. - MACD is below zero and below its signal, with a negative histogram. - OBV and price are both well below their late-September highs. - The high-volume gap days in this data (listed below) suggest event risk.

Levels from the tools to watch

Level	Value	Why it matters
Upside	180.56	Bollinger midline (20 SMA)
Upside	194.48	Daily SuperTrend flip level
Upside	195.54	Upper Bollinger band
Upside	201.97	Closing high of 09-25
Upside	223.47	Weekly SuperTrend flip level
Downside	176.61	10 EMA
Downside	175.42	50 SMA
Downside	172.11	October closing low (10-16)
Downside	168.16	200 SMA
Downside	165.58	Lower Bollinger band

What would shift the read - More bullish: - A bullish MACD cross. - A close above the 180.56 midline, then above 194.48. - OBV making a higher high with price. - More bearish: - A sustained close below the 50 SMA and then below the 200 SMA. - The 200 SMA is the main line separating "range" from "break" in this data.

Event risk (inference, not tool-confirmed): the largest gap and volume days in the series cluster in late October 2025, early February, late April and late July. That suggests a quarterly pattern around reporting dates. Check the earnings calendar, because a report in the coming weeks would likely overwhelm the technical levels above.

8. Gaps in this analysis¶

I did not pull ADX, so I can't say with an indicator whether the market is trending or ranging. The range read comes from price action only.
I did not pull TD-9. It would add an exhaustion count on three timeframes.
I did not pull a fundamental or news source. Nothing here explains the large moves.

Summary table¶

Category	Indicator	Latest value (2026-10-21)	Reading
Price	Close (verified)	178.28	Latest bar looks incomplete (volume about 2.76M)
Trend	10 EMA	176.61	Price above
Trend	50 SMA	175.42	Price above, rising
Trend	200 SMA	168.16	Price above, nearly flat
Trend	SuperTrend weekly	DOWN, stop 223.47	Primary tier bearish
Trend	SuperTrend monthly	UP, stop 116.42	Regime bullish, stop too far to size risk
Trend	SuperTrend daily	DOWN, stop 194.48	Short-term bearish
Momentum	RSI	50.00	Neutral
Momentum	MACD / signal / histogram	-1.24 / -0.42 / -0.82	Below zero and below signal, momentum fading
Volatility	ATR	6.90 (about 3.9% of price)	Cooling from 9.12 on 09-28
Volatility	Bollinger lower / mid / upper	165.58 / 180.56 / 195.54	Price about 42% of the way up the band
Volume	OBV	555.7M	Down from the 606–607M late-September peak, bouncing off about 535M
Stretch	Z-score weekly / monthly / daily	-0.00 / +0.58 / -0.30	No stretch on any tier
Net read	Overall	Mixed, range-like	Bullish MA stack vs. bearish weekly and daily SuperTrend and fading MACD
Key levels	Support / resistance	168.16 (200 SMA) and 165.58 below; 180.56, 194.48 and 201.97 above	The 200 SMA is the pivotal level

Sentiment Analyst¶

Overall Sentiment: Mixed (Score: 5.2/10) Confidence: Low

DATA LIMITS FIRST: Reddit was disabled by config, so there is no community-forum read for QCOM. The news block has headlines and links only, with no article bodies. StockTwits is only 30 messages, of which 8 carry a user label. Confidence is therefore low, and the read below leans on headline-level facts and thin social data.

1) SOURCE-BY-SOURCE BREAKDOWN

News (Yahoo Finance, 19 items for 2026-10-14 to 2026-10-21). About 12 items are QCOM-specific. About 6 are tangential (Broadcom dip-buying, a dividend-ETF piece, two tokenized-stock objection stories, a Liquid AI in-car AI interview, a general 'AI trade is changing' piece). One, StockStory's '3 Semiconductor Stocks We're Skeptical Of', does not say in the headline whether QCOM is among them, so I do not count it either way. - Positive: Susquehanna raised its QCOM price target to $185 from $160 (+15.6%), part of a note that also raised AMD and cut INTC and COHR and described 'modest upside' for chip earnings. Against the roughly $176-177 spot levels quoted on StockTwits, $185 implies only about 5% upside, so it is supportive rather than a strong re-rating. GuruFocus reported ETFs bought $121.4M of QCOM on Oct 19. Zacks said QCOM 'beats stock market upswing'. Qualcomm announced a quarterly cash dividend (amount not stated in the headline). Stocktwits listed QCOM 'in focus' in an up-market earnings-season wrap. - Negative or cautionary: Multiple outlets (Stocktwits, TIKR, GuruFocus) report global, performance-driven layoffs after annual employee reviews. GuruFocus ties them to an 'AI pivot'. StockTwits posts citing Reuters say the cuts start in November, were announced in a CEO Cristiano Amon memo, give no headcount, and apply to a workforce of about 52,000. MT Newswires reported an insider sale of $437,647 (seller and context not given). Insider Monkey frames QCOM as 'automotive growth meets pressure on handset earnings'. MT Newswires also reports a judge 'reluctant to intervene' in Qualcomm-Arm licensing talks, which is an unresolved legal and commercial overhang. The article text is not provided, so the exact ruling and its implications are unknown. - Net news tone: modestly constructive on analyst and flow data, offset by restructuring, a licensing dispute, an insider sale and handset-related earnings pressure. Mildly positive to mixed.

StockTwits (30 most recent messages, Oct 20 12:41Z to Oct 21 14:40Z). Labeled split is Bullish 7 (23%), Bearish 1 (3%), Unlabeled 22. Taken at face value this is a lopsided 7:1 bullish ratio. The sample is tiny and the labels are poor quality, so I do not treat it as a real bullish signal: - George_V2's two 'Bullish' posts are angry rants. They attack CEO Amon and an 'American judge' and say 20,000 Americans will lose jobs. The 20,000 figure is unsupported, since reports say no number was given. They do not read as a bullish QCOM thesis. - jd4308's 'Bullish' post is cheering for $ARM ('this judge is absolutely not allowing a 5 year pause on payments to $ARM'). That is a negative for QCOM, and the user's claim about the ruling is unverified. - TheUnmaker's three 'Bullish' posts are BlackBerry ($BB)-centric multi-cashtag posts where QCOM is incidental. - HappyDonkey's 'Bullish' post actually says the swing-model trend has 'stayed pointed down since early October' and only that an upside inflection 'would be strong'. - Effectively no label-confirmed, QCOM-specific bullish conviction remains. The lone Bearish post (TrumpAndWorld) is a one-line reaction to the layoffs. - Unlabeled content is mostly skeptical or restless about the stock and management: 'CEO totally unable to inspire'; 'so hard to hold onto this immovable object'; 'does this stock ever move more than 1%?'; 'whats new? nothing'; a holder arguing executives and the board should take pay cuts alongside the layoffs. - Speculative upside hopes, unverified: 'withholding a major hyperscaler announcement', and a possible SpaceX/Starlink tie-in. The poster's own AI query said nothing has been confirmed. - Options and promotional flow: a 'repeat sweep' of $QCOM 177.5C Oct 23, $57,900 premium, 1.4x Vol/OI, spot $176.74. This is a small, short-dated, near-the-money call bet with a mild bullish tilt. TopOptionAlert posts (NOV06 180C called at $172.11 on Oct 19 and $176.33 on Oct 20; NOV20 185C with a $175.30-$177.80 zone, invalidation under $173, objectives $187 and $195) are promotional trade-signal content, not independent sentiment. They do show the price rising about 2.5% from Oct 19 to Oct 20 and holding in the mid-$170s. - A Techdamentals post cites the last reported quarter (ended Jun 28) as revenue of $9.95B (-4%) and net income of $2.0B (-25%). This is unverified here, but it matches the 'pressure on handset earnings' headline.

Reddit: no data (disabled). Nothing can be said about r/wallstreetbets, r/stocks or r/investing.

2) CROSS-SOURCE DIVERGENCES AND ALIGNMENTS - Apparent divergence: the StockTwits label ratio looks strongly bullish while the content is skeptical and the news is mixed. After adjusting for mislabeled and off-topic posts, the label ratio mostly collapses, so this is a data-quality artifact more than a real retail-vs-institution split. - Alignment on the layoffs: news and social both treat them as the dominant story. Retail reads them as a negative or a sign of management weakness. The news framing is more neutral ('performance-focused', 'AI pivot'). Price action in the mid-$170s on Oct 20-21 (from promotional posts, not independently verified) shows no obvious selloff, so the market may be treating the cuts as cost discipline. - Alignment on the Arm dispute: both news and retail see the judge's stance as unfavorable to QCOM, though only headline-level information is available. - Institutional vs retail: the one institutional signal (Susquehanna's raise) is positive but modest. Retail excitement rests on rumors (hyperscaler, SpaceX) with no confirmation.

3) DOMINANT NARRATIVE THEMES 1. Restructuring and layoffs: performance reviews, November timing, no headcount, and management credibility. 2. The Arm licensing and legal overhang, read by retail as a loss for QCOM. 3. Handset weakness vs automotive and AI diversification: the bull case rests on auto, AI and data-center optionality, while current results are pressured. 4. Range-bound, low-volatility stock: retail frustration at the 'immovable' price, with analyst targets implying only about 5% upside. 5. Speculation about undisclosed hyperscaler or SpaceX deals, with no confirmation.

4) CATALYSTS AND RISKS Catalysts: - Any confirmed hyperscaler or AI data-center customer announcement, or confirmation of a SpaceX/Starlink relationship (currently rumor only). - Further analyst target raises following Susquehanna. - Continued ETF inflows. - Cost savings from the layoffs. - The dividend announcement, as a modest support for income holders. - The next earnings report. Its date is not in the supplied evidence, so I do not assert it. Risks: - The Arm licensing dispute has no resolution in the data, and the judge's reluctance to intervene leaves the outcome uncertain. - Declining year-over-year revenue and net income per a retail-cited figure (unverified), and handset pressure. - Layoff execution and morale risk, and the lack of a disclosed headcount. - The insider sale ($437,647), which is small in size but adds to the cautious tone. - The swing-model downtrend since early October noted on StockTwits, and failure to hold the $173-$175 area flagged by promotional posts. - The 'no news' fatigue evident in retail posts.

5) SUMMARY TABLE | Signal | Direction | Source | Evidence | |---|---|---|---| | Susquehanna PT raise to $185 from $160 | Mildly Bullish | News / StockTwits | MT Newswires and Stocktwits; about 5% upside vs roughly $176-177; 'modest upside' framing | | ETF inflows | Mildly Bullish | News | GuruFocus: ETFs bought $121.4M on Oct 19 | | Zacks outperformance vs market | Mildly Bullish | News | Headline: 'beats stock market upswing' | | Global performance-based layoffs | Mixed / Bearish-leaning | News / StockTwits | Stocktwits, TIKR, GuruFocus; November start; no headcount; about 52,000 employees; retail reads it as a negative | | Qualcomm-Arm licensing, judge reluctant to intervene | Bearish risk | News / StockTwits | MT Newswires headline; retail reads it as a win for $ARM (unverified) | | Insider sale | Mildly Bearish | News | MT Newswires: $437,647 (context not given) | | Handset pressure vs auto growth | Mixed | News | Insider Monkey headline; retail-cited revenue -4% and net income -25% (unverified) | | Dividend announcement | Neutral to Mildly Bullish | News | PR Newswire; amount not stated | | StockTwits label ratio | Bullish on face, low quality | StockTwits | 7 Bullish (23%), 1 Bearish (3%), 22 unlabeled; most bullish tags are mislabeled or off-topic | | Retail tone in unlabeled posts | Skeptical / Neutral | StockTwits | 'CEO totally unable to inspire'; 'whats new? nothing'; 'immovable object' | | Short-dated call flow | Mildly Bullish | StockTwits | 177.5C Oct 23 repeat sweep, $57,900 premium, 1.4x Vol/OI, spot $176.74 | | Hyperscaler / SpaceX rumors | Speculative, unverified | StockTwits | Poster's own AI query: nothing confirmed | | Swing-model trend | Mildly Bearish | StockTwits | HappyDonkey: down since early October | | Reddit | No data | Reddit | Disabled by config |

BOTTOM LINE: Sentiment is mixed to lukewarm. A modest analyst and flow tailwind is offset by restructuring, Arm legal overhang, an insider sale and fundamentals under pressure. The StockTwits bullish ratio is not reliable. This is sentiment signal only, to be weighed against fundamentals and technicals, and is not a price call.

News Analyst¶

QCOM (QUALCOMM Incorporated) news and macro report, week of 2026-10-14 to 2026-10-21¶

1. Data coverage¶

Company news (works): The tool returned headlines and sources only, with no article text. I can't verify figures beyond what a headline states.
Global news (works, but weak): Mostly earnings-season and thematic filler, with little hard macro content.
FRED macro data (failed): Every call failed, including fed_funds_rate, 10y_treasury, cpi, unemployment, yield_curve and vix. I retried with raw IDs (DFF, DGS10) and got a 403 Forbidden error. I have no readings for rates, inflation, labor or volatility, and I haven't estimated any.
Prediction markets (works): Fed, recession and QCOM-specific markets returned data. Some are very thin.

2. QCOM company developments¶

Sell-side and flows (constructive) - Price target raise: Susquehanna raised its QCOM target to $185 from $160 (MT Newswires). A Stocktwits headline groups this with a "modest upside" view on chip earnings. It lists AMD and QCOM as raised, and INTC and COHR as cut. - ETF buying: ETFs bought about $121.4M of QCOM on Oct. 19 (GuruFocus). - Relative strength: Zacks says QCOM "beats stock market upswing". I don't have the price or percentage move. - Dividend: Qualcomm announced its regular quarterly cash dividend (PR Newswire). The amount and dates aren't in the headline.

Restructuring (mixed) - Several outlets (Stocktwits, TIKR, GuruFocus) report global layoffs following performance-focused employee reviews. GuruFocus ties them to an accelerating "AI pivot". - The headcount and cost savings aren't in the headlines. This could read as cost discipline and reallocation toward AI and data center. It could also point to pressure in the legacy handset business.

Business-mix narrative - Insider Monkey frames the story as "automotive growth meets pressure on handset earnings." This matches the long-running diversification-versus-handset-dependence debate. - A TheStreet piece quotes the Liquid AI CEO saying AI's next big opportunity may be inside cars. That is thematically supportive of Qualcomm's automotive and edge-AI positioning, but it isn't company-specific news.

Legal and licensing - Arm: MT Newswires reports a judge is reluctant to intervene in Qualcomm-Arm licensing talks. This reads as no court-imposed resolution soon, so the license relationship stays a negotiated, unresolved overhang. The headline is the only detail I have.

Insider activity - An insider sold shares worth about $437,647 per an SEC filing. That is small and routine in size, and it isn't a strong signal on its own.

Caution - StockStory's "3 Semiconductor Stocks We're Skeptical Of" appeared in the QCOM results. I can't confirm QCOM is one of the three, so don't treat it as a negative call on QCOM.

3. Upcoming catalyst: fiscal Q4 earnings¶

A Polymarket contract on QCOM's Q4 QCT (chip) revenue resolves 2026-11-04. That suggests earnings land around then, but I haven't confirmed the date.
Implied odds: QCT revenue above $8.5B at 63%, and above $9.5B at 10%.
Reliability is very low. Volume is only about $300–$340 per contract. Treat this as anecdotal, not a consensus read.
The Susquehanna raise and the "handset pressure" narrative suggest the setup into earnings is debated.

4. Macro and market backdrop¶

Fed (the best data this week) - October FOMC (resolves 2026-10-29):

Outcome	Probability	1-week change
Hold	86%	+20.0pp
25bp hike	14%	-19.5pp
Any cut	~0%	—

Volumes are deep ($7M–$15M), so these readings are more credible than the QCOM contracts.
A hike was priced at roughly a third a week ago, and that tail has mostly collapsed. I'm inferring the earlier level from the stated one-week change.
Full-year 2026: "No Fed cuts in 2026" is at 97% ($9.0M volume).
Implication: The market prices a hold-or-hawkish path with no easing. That is a "higher for longer" regime, which weighs on long-duration tech multiples. A hawkish surprise, or a dissent-heavy meeting, is the main macro risk. The "no dissent" contract sits at 24%, down 11pp on the week.

Growth - US recession by end-2026: 8% ($2.3M volume). The UK is at 6% and Japan at 4%, both on thin volume. Markets see low recession risk, which supports cyclical semiconductor demand.

Equity tape and themes (from headlines) - Stocks were bid into earnings season. S&P 500 and Dow gains were noted, and Meta, Tesla and IBM reports were pending. - A 24/7 Wall St. headline says "The AI Trade Is Changing," which fits a rotation within AI beneficiaries. I only have the headline. - Silver is described as showing "more resilience than gold." - Large firms (Goldman, Microsoft, Alphabet, McDonald's) are pushing back on tokenized versions of their stocks. This is not relevant to QCOM.

Gaps - I have no data on CPI, core PCE, unemployment, the 10-year yield, the yield curve or VIX. - Polymarket had no semiconductor-tariff or export-control markets, so I can't quantify trade-policy risk. This matters for QCOM given its China and handset exposure.

5. Takeaways for traders¶

Sentiment skews mildly positive. The PT raise, ETF inflows and relative outperformance all point that way. The inputs are headlines only, so confirm price levels elsewhere.
Layoffs and the AI pivot are ambiguous. The market could read them as margin-accretive or as a sign of handset stress. Watch how management frames the restructuring and AI and automotive guidance at earnings.
Earnings around early November are the main company catalyst. Positioning into the print matters. The QCT revenue contracts are too thin to rely on.
The Fed on Oct 28–29 is the main macro event. The base case is a hold at 86%, but the 14% hike tail and the lack of any cuts argue against assuming multiple expansion.
The Arm licensing issue is unresolved. No court shortcut appears likely, so keep it as a background risk.
Verify the macro inputs. The rates, inflation and VIX data failed. Another source should fill that gap before sizing risk.

6. Summary table¶

Category	Item	Detail	Signal / read
Analyst	Susquehanna PT	$160 → $185	Positive
Flows	ETF buying	~$121.4M bought Oct 19	Positive
Price action	Zacks note	QCOM outperformed a market upswing	Mildly positive (no figures)
Corporate	Layoffs	Global cuts after performance reviews, tied to the AI pivot	Ambiguous
Corporate	Dividend	Regular quarterly dividend announced	Neutral to supportive (amount unknown)
Insider	Share sale	~$437.6K	Minor, routine in size
Legal	Qualcomm–Arm	Judge reluctant to intervene in licensing talks	Unresolved overhang
Business mix	Auto vs handset	Auto growth against handset pressure	Key debate
Catalyst	Fiscal Q4 earnings	Likely around Nov 4 (inferred)	Main upcoming event
Prediction mkt	QCT revenue >$8.5B / >$9.5B	63% / 10%	Very low reliability (<$400 volume)
Fed	Oct FOMC	Hold 86%, hike 14%, cut ~0%	Hawkish tail faded (hike -19.5pp on the week)
Fed	2026 cuts	"No cuts" 97%	Higher for longer
Growth	US recession 2026	8%	Low risk priced
Macro data	CPI, unemployment, 10Y, curve, VIX, fed funds	Unavailable (FRED 403 and parse errors)	Data gap
Policy risk	Semiconductor tariffs	No markets found	Not quantifiable
Caveat	Headlines only	No article text	Verify details before acting

Fundamentals Analyst¶

QCOM (QUALCOMM Incorporated) Fundamental Report¶

As of 2026-10-21. Sector: Technology / Semiconductors. Exchange: NMS.

1. Bottom line¶

Growth has stalled and profitability is slipping. Revenue was a record in FQ1 FY26 (Dec-25 quarter, $12.25B). It then fell year over year in FQ2 (−3.5%) and FQ3 (−4.0%).
Operating income fell much faster than revenue. FQ3 operating income was down 41% year over year, with operating margin at 16.3% versus 26.6% a year earlier. Gross margin fell about 2.5 points and implied operating costs rose about 22%.
Cash generation weakened sharply. FQ3 operating cash flow was about $1.0B, down roughly 66% year over year. Capex has roughly doubled.
Headline GAAP earnings are distorted. The TTM EPS of $8.64 nets a large implied loss in FQ4 FY25 against a large gain in FQ2 FY26 (see §3). Trailing P/E (20.6x) and forward P/E (17.5x) are probably on different bases.
Insider activity is mostly selling, and none of the sales read as a strong signal. There were no open-market buys in the 22-month window. Most sales look programmatic.
Likely catalyst: the September-quarter (FQ4) and full-year results are not yet in the data. QCOM has historically reported in early November, but that date isn't in the tools, so please verify it.

Nothing new was filed in the past week. The latest financials are for the quarter ended 2026-06-28. The only fresh item is a COO share sale on 2026-10-20.

2. Snapshot and valuation (vendor data)¶

Metric	Value	Comment
Market cap	$190.4B
Implied price	~$178	P/E × EPS and P/B × book value both give about $178.3
P/E (TTM) / Forward P/E	20.6x / 17.5x	TTM is distorted by one-offs
EPS (TTM) / Forward EPS	$8.64 / $10.19	Forward is likely non-GAAP, so not like-for-like
PEG	0.78	Relies on growth estimates that recent revenue doesn't support
P/B / Book value	6.8x / $26.17
Dividend yield	2.09%	Implies about $3.7 per share per year (derived)
Beta	1.65	High volatility, so size positions accordingly
52-week range	$121.99 – $259.92	Price is about 31% below the high and 46% above the low
50-day / 200-day average	$175.39 / $169.39	Price is slightly above both
Revenue (TTM) / Gross profit	$44.07B / $23.90B	Gross margin about 54.2%
EBITDA / Net income	$12.0B / $9.26B
Profit / Operating margin	21.0% / 18.5%	Net margin is flattered by one-offs
ROE / ROA	33.8% / 11.6%	ROE is inflated by the one-time gain and a historically small equity base
Debt/Equity	55.2%	Implies total debt of about $15B (derived)
Current ratio	2.02	Matches the balance sheet: $23.0B current assets ÷ $11.4B current liabilities
Free cash flow (TTM)	$10.24B	FCF yield about 5.4%

Rough EV/EBITDA is about 17x. That uses my derived ~$15.3B debt and cash of $4.5B. The tools don't provide marketable securities, so EV is probably overstated.

3. Income statement (quarterly, $M)¶

FY ends in late September. The tool omits September quarters, which come from the 10-K. FQ4 FY25 figures below are derived by subtracting the three reported quarters from the vendor's TTM, so treat them as approximate. Gross margin is computed as (revenue − cost of revenue) ÷ revenue, because the gross profit row is unavailable.

Quarter	Revenue	YoY	Gross margin	Operating income	Op margin	Net income	Diluted EPS
FQ1 FY25 (Dec-24)	11,669		55.8%	3,555	30.5%	3,180	2.83
FQ2 FY25 (Mar-25)	10,979		55.0%	3,120	28.4%	2,812	2.52
FQ3 FY25 (Jun-25)	10,365		55.6%	2,762	26.6%	2,666	2.43
FQ4 FY25 (Sep-25), derived	~11,271		n/a	n/a	n/a	~−3,116	~−2.89
FQ1 FY26 (Dec-25)	12,252	+5.0%	54.6%	3,366	27.5%	3,004	2.78
FQ2 FY26 (Mar-26)	10,599	−3.5%	53.8%	2,309	21.8%	7,370	6.88
FQ3 FY26 (Jun-26)	9,947	−4.0%	53.1%	1,626	16.3%	2,002	1.87

Key observations 1. The revenue drop is larger than seasonal. FQ3 revenue is 18.8% below FQ1 FY26. The same FQ1-to-FQ3 gap was about −11% in FY25 and −5.5% in FY24. Nine-month FY26 revenue is $32.8B versus $33.0B a year earlier (−0.7%). 2. Operating deleverage is the main issue. Nine-month operating income is $7.30B versus $9.44B a year earlier (−22.6%). Operating income fell 5% year over year in FQ1, 26% in FQ2 and 41% in FQ3. 3. Implied operating costs are accelerating. Gross profit minus operating income was up about 12% year over year in FQ1, 16% in FQ2 and 22% in FQ3, while revenue shrank. The tool doesn't break out R&D, SG&A or restructuring, so the cause is not identified. 4. Gross margin is down about 2.5 points year over year (53.1% versus 55.6% in FQ3), so mix or pricing pressure is plausible. The data doesn't confirm a cause. 5. Earnings quality is weak. - FQ2 FY26 net income of $7.37B is more than three times operating income ($2.31B). That implies a non-operating or tax gain of about $5B. - The implied FQ4 FY25 loss of about $3.1B points to a mirror-image charge. The tools don't itemize either item, so I can't confirm the cause. A tax valuation allowance and its later reversal is a hypothesis to check in the 10-Q and 10-K. - Even in FQ3 FY26, net income ($2.0B) exceeds operating income ($1.6B), so below-the-line items are helping EPS. - FQ3 EPS fell 23% year over year while operating income fell 41%. 6. Context. FQ1 FY26 is the highest revenue quarter in the dataset, which goes back to 2008. FQ3 FY19 operating income of $5.3B is a known one-off from the Apple settlement.

4. Balance sheet (latest 2026-06-28, $M)¶

Item	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25
Total assets	57,367	57,136	53,034	50,143	54,862
Current assets	23,004	23,112	24,608	25,754	24,913
Cash & equivalents	4,533	5,435	7,205	5,520	5,448
Total liabilities	29,709	29,858	29,961	28,937	27,653
Current liabilities	11,413	9,767	9,822	9,144	7,800
Stockholders' equity	27,658	27,278	23,073	21,206	27,209

Equity dip and rebuild. Equity fell to $21.2B in Sep-25, consistent with the implied FQ4 FY25 loss. It rebuilt to $27.7B by Jun-26, helped by the FQ2 gain.
Total assets rose about $7.2B from Sep-25 to Jun-26. Part of the rise is likely the same tax item.
Cash and equivalents are at $4.5B. That is down 37% from Dec-25 and the lowest since early 2023. Marketable securities aren't in the tool, so total liquidity is understated here.
Current liabilities are up 46% in a year ($7.8B to $11.4B). The mix isn't broken out, so check for short-term debt maturities and accrued liabilities.
Leverage is moderate. Total liabilities are 1.07x equity, and the vendor D/E is 55%. The tool has no debt, interest or marketable-securities lines.

5. Cash flow¶

The statements are year-to-date cumulative. I differenced them into quarters.

($M)	9M FY26	9M FY25	Change
Operating cash flow	8,405	10,016	−16%
Capex	1,578	785	+101%
Free cash flow (OCF − capex)	6,827	9,231	−26%
Investing cash flow	−1,648	−329
Financing cash flow	−10,046	−9,760

Derived quarter	FQ1 FY26	FQ2 FY26	FQ3 FY26	FQ3 FY25
Operating cash flow	4,965	2,449	991	2,875
Capex	549	533	496	294
FCF	4,416	1,916	495	2,581

FQ3 FCF fell about 81% year over year. Cash conversion has dropped sharply. The cause could be working capital, taxes or timing. The tools don't say, so confirm it on the next call.
The vendor's TTM FCF of $10.24B is flattered by the strong FQ1 and the implied FQ4 FY25. The latest-quarter run rate is far lower.
Capex is running at about $2.1B a year, versus roughly $1B in recent years. The purpose isn't identified in the data.
Shareholder returns exceed FCF. Financing outflows were about $10.0B in nine months against FCF of $6.8B. These outflows are mostly buybacks and dividends, but the tool doesn't split out debt repayment. The gap of about $3B was funded by drawing down cash and securities and possibly by debt. The dividend alone is about $4B a year (derived), which is covered about 2.3–2.6x by FCF.
Data caveat. Operating, investing and financing flows for nine months of FY26 sum to about −$3.3B. The balance-sheet cash change from Sep-25 to Jun-26 is about −$1.0B. FX, restricted cash or tagging issues may explain this. Treat the investing and financing detail with some caution.

6. Insider transactions (150 records, Dec 2024 to 2026-10-20)¶

Last week: - COO Akash Palkhiwala sold 2,500 shares on 2026-10-20 at $171.88–$176.58 (about $438K), direct ownership.

Patterns - COO: - He has sold nearly every month: 2,500 shares a month since Mar-26, 3,333 a month from mid-2025 to Feb-26, and 12,538 in Dec-25. - Since Apr-26 he has sold about 17,500 shares for about $3.1B... correction: about $3.1M in total. - Sale prices ranged from about $130 to $227, which looks like a pre-set plan rather than price timing. - CEO Cristiano Amon (indirect): - 10,000 shares at $195 on 2026-09-21 ($1.95M). - 10,000 shares each at $180 and $185 in May-26. - 150,000 shares at about $165.9 on 2025-10-01 ($24.8M), the largest sale in the dataset. - These total about 180,000 shares and about $30.4M. The round-number prices suggest limit-order tranches. - Other officers: - Heather Ace sells 3,200 shares roughly quarterly (Feb, May and Aug 2026). She gifted 26,542 shares on 2026-02-19. - Patricia Grech makes small, frequent sales. - In Dec-25, General Counsel Ann Chaplin sold about $1.28M and Officer Alexander Rogers sold about $2.83M. - Directors show only $0 stock awards, which are grants rather than purchases. - Buys: none in the window. Several rows have blank transaction types, probably vesting or tax withholding, but that is unconfirmed.

Read-through: this is a net-selling pattern with low information content, since the sales are regular, size-fixed and happen at both low and high prices. It gives no bullish confirmation. Insiders did not buy at $122–$180.

7. Data limitations¶

September quarters are missing, so the FQ4 FY25 figures are derived.
The gross profit row is unavailable and was computed.
The balance sheet has no debt or marketable-securities lines. EV, net cash and interest coverage are therefore approximations.
The tools give no segment data (handsets, auto, IoT), guidance, tax detail or the reasons for the margin and cash-flow changes. I haven't confirmed any explanation (for example handset demand or customer modem insourcing). Check those against news and the filings.
The vendor snapshot date is unclear.

8. Implications for traders¶

This report doesn't make the trade call. 1. Fundamental trend is negative. Revenue, gross margin, operating margin and FCF all weakened in the last two quarters. The forward P/E of 17.5x assumes a recovery toward $10.19 of EPS. The next report needs to show that. 2. Don't anchor on trailing EPS of $8.64 or ROE of 34%. One-off tax or non-operating items drive both. 3. Watch in the FQ4 and full-year print: - revenue against the seasonal norm - gross margin versus 53% - operating cost growth (about +22% year over year) - operating cash flow rebound - cash balance and buyback pace - the explanation of the FQ2 and FQ4 tax and non-operating items - capex guidance and the FQ1 FY27 outlook 4. Risk sizing. Beta is 1.65 and the stock has swung between $122 and $260 over the year, so an earnings reaction could be large in either direction. The 2.1% dividend yield and a low-risk current ratio of 2.0 give some support. 5. Insider flow is not a reliable signal either way. Watch for any open-market buying, which would be new information.

9. Summary table¶

Area	Key point	Evidence	Read
Valuation	Forward P/E 17.5x, TTM 20.6x, PEG 0.78	Price about $178	Fair if EPS recovers; bases not like-for-like
Revenue	Two straight year-over-year declines	FQ2 −3.5%, FQ3 −4.0% after a record FQ1	Negative
Gross margin	Down about 2.5 points year over year	53.1% vs 55.6%	Negative
Operating income	FQ3 −41% year over year	$1.63B vs $2.76B; margin 16.3%	Negative
Operating costs	Implied growth accelerating	+12%, +16%, +22% year over year	Negative
Earnings quality	Large one-offs	FQ2 net income $7.37B vs operating income $2.31B; FQ4 FY25 implied about −$3.1B	Caution
Cash flow	FQ3 FCF −81% year over year	$0.5B vs $2.6B; capex doubled	Negative
Shareholder returns	Exceed FCF	$10.0B financing outflow vs $6.8B FCF over nine months	Watch sustainability
Balance sheet	Moderate leverage, low cash	Cash $4.5B; D/E 55%; current ratio 2.0	Neutral
Insiders	Net selling, programmatic, no buys	COO monthly 2,500 shares; CEO about $30M since Oct-25	Neutral to mildly negative
Technicals (context)	Between averages, below 52-week high	$178 vs 50-day $175 and 200-day $169; high $259.92	Neutral
Catalyst	FQ4 and full-year report	Typically early November (unverified)	High-impact event
Data gaps	No debt or securities lines, no segments, no tax detail	Tool limitations	Verify in filings

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for QCOM: A Reset Business at a Reset Price

I'll open with the thesis. QCOM is a cash-generative, dividend-paying semiconductor franchise whose stock has already round-tripped from $123 to $249 to $178. Operating results are at a cyclical low point, and the biggest drag on earnings is a cost line that management is now cutting. I'm leaning on the tool data throughout and will flag where it runs out.

1. The reset is smaller than the headlines suggest¶

The bear will point to two straight quarters of falling revenue. Here is the fuller picture:

Nine-month FY26 revenue is $32.8B versus $33.0B a year ago, down 0.7%. That is a flat top line, not a collapse.
FQ1 FY26 was the highest-revenue quarter in the dataset, which goes back to 2008, at $12.25B (+5.0% YoY). The franchise recently showed its peak earning power.
FQ2 and FQ3 declines were -3.5% and -4.0%. That is a soft handset patch, not demand destruction.
Gross margin is still 53.1%. It is down about 2.5 points, but that is a high-margin business under mild pressure, not a broken one.

2. The profit decline is mostly a cost story, and cost is controllable¶

FQ3 operating income fell 41%, and that is the bear's best number. Here is my arithmetic from the tool's figures:

FQ3	FY25	FY26	Change
Gross profit	~$5.76B	~$5.28B	-$481M
Implied operating costs	~$3.00B	~$3.66B	+$655M
Operating income	$2.76B	$1.63B	-$1.14B

About three-fifths of the operating income decline came from cost growth, not from lost gross profit. If costs had merely stayed flat, FQ3 operating income would have been about $2.28B, down roughly 17% instead of 41%. The tools don't break out R&D, SG&A or restructuring, so I can't say how much of that growth is deliberate AI investment versus one-time items. Either way, it is discretionary spending, not lost demand.

Management has now announced performance-based global layoffs starting in November, at a company of about 52,000 people. No headcount has been given, and the news only describes it as tied to an "AI pivot". It is reasonable to read this as the cost base being reallocated, and I'll watch how it is framed at earnings.

3. Valuation already prices in a lot of pessimism¶

Forward P/E is 17.5x, PEG is 0.78, the FCF yield is about 5.4% and the dividend yield is 2.09%. I treat the forward EPS of $10.19 as probably non-GAAP and not like-for-like, and I'm not leaning on trailing EPS of $8.64.
The stock is 28% below its May closing peak ($248.74) and 31% below its 52-week high ($259.92). The tools don't say what drove the spring surge, which started with a gap from $132.73 to $147.50 on about 29M shares on April 24. The market showed it would pay far higher prices when the narrative clicked, so mean reversion toward the middle of that range is plausible if results stabilize.
Susquehanna raised its target to $185 from $160. That is only about 4% above the current price, so it's a conservative marker and not a stretch call.

4. The balance sheet can carry the payout¶

The current ratio is 2.02, and total liabilities are 1.07x equity.
TTM FCF is $10.24B, and nine-month FCF of $6.8B covers the roughly $4B annual dividend about 2.3x or better.
Capex has roughly doubled, to about $2.1B a year. The tools don't say what it funds, but a company in retreat doesn't usually step up investment.

5. The tape is constructive and not stretched¶

The MA stack is bullish. Price (178.28) is above the 10 EMA (176.61), the 50 SMA (175.42, rising) and the 200 SMA (168.16).
The October 15 intraday low of 168.84 held just above the 200 SMA (168.08 that day). I'll concede this is one touch, not validated support.
The monthly SuperTrend is UP.
RSI is 50, the daily z-score is -0.30 and ATR has cooled from 9.12 to 6.90. Nothing is overbought, and the stock is neither chased nor panic-sold.
ETFs bought about $121.4M of QCOM on Oct 19.
The retail crowd is bored. Posts say "whats new? nothing" and "immovable object", and the layoff news didn't dent the price. Skeptical, tired holders ahead of a catalyst are a better setup than euphoria.

6. The macro backdrop favors a high-beta semiconductor name¶

The Fed is 86% likely to hold on Oct 29. The hike tail fell 19.5 points in a week, from roughly a third to 14%.
"No cuts in 2026" is already at 97%, so higher-for-longer isn't news.
The US recession probability is 8%. That supports semiconductor demand, and with a beta of 1.65, a calm macro setup helps this stock more than most.

Pre-empting the bear's strongest points¶

"Earnings quality is awful." I agree the FQ2 net income of $7.37B and the implied FQ4 FY25 loss of about $3.1B are distorted by non-operating or tax items. That is why I anchor on the operating line, FCF and the dividend.
"FQ3 FCF fell 81%." It did, to about $0.5B from $2.6B. That is one quarter, and the cause isn't identified in the data, so it could be working capital or timing. Nine-month FCF is down 26%, a meaningful decline but not a breakdown.
"Shareholder returns exceed FCF." Nine-month financing outflows were $10.0B against FCF of $6.8B, and cash is down to $4.5B. The tools exclude marketable securities, so liquidity is understated. Still, the gap can't last forever.
"The weekly SuperTrend is DOWN." It is, with a flip level of 223.47. It is anchored to the May–June peak, so it is mostly a statement that price is below the spike. It is a lagging indicator.
"Arm is an overhang." I agree, but the evidence is one headline saying the judge is reluctant to intervene. That points to a negotiated status quo and not a new quantified cost.
"Insiders are selling." The COO sells 2,500 shares a month (about $438K on Oct 20), and the CEO's sales are in round-number tranches. Those look like pre-set plans, not signals.

What would make me wrong¶

I'd turn cautious if the FQ4 print, likely in early November but unverified, shows gross margin below about 53% with operating costs still growing around 20%, no FCF rebound, or a sustained close below the 200 SMA at 168.

Bottom line¶

The market has already priced a hard year, but this is a franchise with flat nine-month revenue, 53% gross margins, a covered dividend and a controllable cost line, trading at 17.5x forward earnings. The upside to the May closing peak is about 40%, against a downside to the 200 SMA of about 6%.

I'd like to hear the bear's case for why operating costs won't normalize and why the FQ3 cash flow weakness is structural and not timing. Bull Analyst: # Bull Rebuttal: I Concede the Trend, Not the Extrapolation

You asked for a single data point showing the cost line or cash flow has stopped deteriorating. There isn't one. The fundamentals tools end at the June quarter, and nothing in them shows a turn. I won't invent one. My argument is narrower. The cost line looks like discrete steps, not a compounding slide. Over nine months, cash has held up better than your FQ3 snapshot suggests. And every test you set can be answered in about two weeks.

What I concede¶

My 40% vs. 6% framing was loose. It compared a spike peak to a nearby moving average. I restate it below.
PEG 0.78 implies about 22% growth that the revenue trend doesn't support. I'm dropping it. The tools also give no peer or historical multiple, so I can't call QCOM cheap, and you can't call it expensive.
FQ3 dividend coverage was about 0.5x.
ETF flow and StockTwits labels are noise. I also concede that MA-stack arguments are as lagging as SuperTrend ones, and that the missing FRED data leaves "calm macro" partly unverified.
My tripwires are close. Gross margin of 53.1% and opex growth of 22% sit right at the lines I drew.

Where you overreach¶

1. Opex looks like steps, not compounding. Your table uses YoY percentages. In dollars (my arithmetic from tool figures):

	FQ3 FY25	FQ1 FY26	FQ2 FY26	FQ3 FY26
Implied opex	~$3.00B	~$3.32B	~$3.39B	~$3.66B
Sequential			+$70M	+$263M

It rose from the FY25 level of roughly $2.9–3.0B, held nearly flat in FQ2, then stepped up again in FQ3. That pattern looks like decisions (hiring, AI projects, possibly one-time items), not drift. Decisions can be reversed, and the layoff memo is evidence that management is trying to do so. The tools can't tell me what is inside the steps, so this isn't proof. It does mean "+12, +16, +22 compounds" overstates the case.

2. Nine-month cash conversion isn't broken.

OCF ÷ operating income	FQ1	FQ2	FQ3	9M FY26	9M FY25
	147%	106%	61%	115%	106%

Nine-month OCF fell 16%, while nine-month operating income fell 22.6%. FQ1 and FQ3 look like mirror-image outliers. Your "OCF was 108% of net income, now 50%" uses net income, which you and the fundamentals report both flag as distorted. On operating income, FQ3 went from 104% to 61%. That is still a real drop, and I won't call it timing yet. I accept your bar: FQ4 OCF of $2.5B or more is the test.

3. Your 1.3x leverage figure double-counts. You strip the ~$5B FQ2 gain from equity but leave the FQ4 FY25 loss in the base. Equity was $27.2B in Jun-25, before either item, and is $27.7B now. Liabilities-to-equity went from 1.02x to 1.07x, not 1.3x. I still grant that cash is the lowest since 2023 and current liabilities are up 46% with the mix unknown.

On "either buybacks slow or leverage rises": the buyback is the valve, not the dividend. Rough math: ~$10.0B of nine-month financing outflows minus ~$3.0B of dividends leaves ~$7B, or ~5% of market cap annualized. That figure also includes any debt repayment, which the tools don't split out. Halving it costs perhaps 2–3% of annual EPS accretion. That isn't the difference between $10.19 and a broken thesis. The dividend (~$4B a year) is covered 2.3x on nine-month FCF and 2.6x on TTM.

4. "Price ran ahead of profits" cuts both ways. The FQ3 numbers have been public since roughly late July (inferred from the June 28 quarter end), and the stock is +21% since the July 31 close. The tape's big gap days also look like earnings reactions (inferred from the technical report's quarterly pattern):

Feb 5: -8.5% after a record-revenue FQ1.
Apr 24: +11% gap after an FQ2 with operating income down 26%.

The stock has not traded on the trailing P&L table. I can't say what it did trade on, and that is a gap in my case too. But it means your table alone doesn't call the next move.

5. Risk/reward, restated with tool levels:

	Level	vs. 178.28
Upside	194.48 (daily flip) / 201.97 (Sep high) / 223.47 (weekly flip)	+9% / +13% / +25%
Downside	168.16 (200 SMA) / 146.81 (Jul close)	-6% / -18%

That is roughly 1.4–2.3x in favor of upside. It's a modest positive skew with fat tails on both sides, given ATR of 3.9% and beta of 1.65.

The scoreboard for the print¶

I'm replacing YoY opex tests with dollar tests, because the FQ4 FY25 base isn't in the tools.

Test	FQ3 FY26	Bear confirmed	Bull confirmed
Implied opex	~$3.66B	≥ $3.7B	≤ ~$3.5B (back toward the FQ1–FQ2 run rate)
Gross margin	53.1%	< 52.5%	≥ 53%
OCF	$0.99B	< $1.5B	≥ $2.5B
Cost plan	headcount undisclosed	no figures	quantified savings
Price	178.28	close < 168	reclaim 180.56, then 194.48

What I'd do¶

I'd hold a starter position sized for an 18% gap, not for the 200 SMA stop. A gap can skip it, as you noted. I'd add on evidence from the print: opex retracing, OCF rebounding and a quantified cost plan. I'd cut on a close below 168 or if opex prints at or above $3.7B with no plan. This is a dividend-paying franchise with a reversible cost step and an observable test two weeks out. It isn't a statistical bargain.

My question back¶

You call the stock fairly priced, and the extrapolations (52.4% gross margin, opex up 22% or more) are public. For your downside to play out, the print must be worse than the trend anyone can draw. For mine, it must be better. Management just announced a cost action, so which is likelier? And if opex comes in near $3.4B with OCF at or above $2.5B, do you flip, or does a new bar appear? Bull Analyst: # Bull Rebuttal: The Print Is a Coin-Flip, and I Won't Pretend Otherwise

You're right on the calendar, the targets and the starter. You're wrong on three numbers, and your two questions have honest answers that cost me some of the trade.

What I'm conceding¶

Savings can't show up in FQ4. My ≤$3.5B opex bar therefore doesn't test the layoffs. It tests whether the FQ3 step (+$263M sequentially) was non-recurring or paused. The tools can't tell me which.
The 194.48 and 223.47 levels are trailing-stop flips, not targets. I'm dropping them.
The layoff math has two unknowns. We don't know how much of the $655M YoY increase is people cost, or how much is one-time or non-headcount (legal, compute, depreciation on doubled capex). Neither of us should lean on "9,400 jobs."
The success case is stabilization at a lower level, not a reset price. I'm retiring "cheap." My claim is "not stretched, with a reversible cost step."
The starter has no print-specific evidence behind it. More on that below.

Where your numbers need fixing¶

1. "No observed interval declined." Implied opex went from ~$2,956M in FQ1 FY25 to ~$2,918M in FQ2 FY25 (my arithmetic, rounded margins, ±$10M). Across the three FY25 quarters it stayed at $2.9–3.0B while revenue fell 11% ($11.7B to $10.4B). The decline is trivial, but it shows opex is a policy variable. It was held flat once and stepped up in FY26. It also shows opex doesn't fall just because revenue does, so I'm not claiming reversion is automatic.

2. The 27x uses the seasonal trough. FQ3 is the lowest-revenue quarter in the series, and ×4 gives $39.8B against TTM of $44.1B. You also can't annualize FQ3 for the success case while arguing FQ4 revenue is seasonally up 8.7%. Take TTM revenue less 4% (~$10.6B a quarter), 53.1% gross margin and $3.5B of opex. That gives ~$2.1B a quarter, or ~$8.4B a year, which is about 23x. That's still not cheap, but it's not 27x.

3. "+21% since July 31." True, but July 31 was the trough of a 41% slide. From the Sept 25 close of 201.97 the stock is down 11.7%, and October has traded 172–185. It has de-rated into the print, not run into it.

One caveat on the YoY test. The FQ4 FY25 base is derived, and it contains a ~$3.1B net loss. The vendor's 18.5% operating margin looks TTM-consistent, since profit margin ties to TTM net income. If so, it would imply FQ4 FY25 operating income of only ~$0.85B. I can't verify that, and the tools mark it n/a. If it's right, the YoY headline on this print could look odd in either direction. That's another reason to judge dollar levels, as we've both been doing.

Your question 1: my probabilities¶

Line	Bull zone	Odds	Middle	Odds	Bear zone	Odds
Implied opex	≤ $3.5B	20%	$3.5–3.7B	45%	≥ $3.7B	35%
Gross margin	≥ 53.0%	45%	52.5–53.0%	30%	< 52.5%	25%
OCF	≥ $2.5B	35%	$1.5–2.5B	40%	< $1.5B	25%

The lines are correlated. All three in the bull zone is ~12%, which is below your one-in-five. By bucket, I put Bull 25%, Middle 50%, Bear 25%, with the bull bucket meaning at least two bull-zone lines and none in the bear zone.

With reactions of roughly +11%, ~0% and −11% (your ±10% event moves, which are inferred), the expected print move is about zero. My error bars on those odds are larger than any edge. I have no data that tilts it. The one tilt I'd claim is that cost is the line management controls, and that isn't enough to call the print positive-EV.

What the scoreboard is missing¶

Our P&L scoreboard has a blind spot, and it cuts both ways. The stock fell 8.5% on a record-revenue FQ1 and gapped +11% on an FQ2 with operating income down 26%. The big gap days also don't all line up with prints. The technical report lists late October 2025 as an event cluster, while the fundamentals report says the Sept-quarter print is typically early November. If both are right, at least one major move wasn't earnings. The price has traded on something outside the P&L. I can't say what, and that narrative deflated once already (−41% to July). I'm adding two rows:

Test	Bull	Bear
FQ1 FY27 revenue guide (my thresholds)	≥ ~$11.8B (no worse than −4% YoY vs. the $12.25B record comp)	< ~$11.3B (≈ −8%)
AI, auto and data-center commentary	Quantified	Vague

The record FQ1 FY26 is a hard comp for the next quarter. That's a weakness in my thesis, and you shouldn't have to find it yourself.

Your question 2: the middle print¶

Opex $3.6B, gross margin 52.9%, OCF ~$2.0B, no savings figure:

No add. The thesis is unconfirmed.
Keep the starter only if the stock closes above 168 after the print and the FQ1 guide isn't in the bear zone. Otherwise I cut.
Don't chase a pop. If a middle print gaps up more than ~8%, I trim. The P&L wouldn't justify it.
Time stop at the FQ1 FY27 print (February). That's the first quarter with the layoffs live. If opex isn't near $3.5B there, I'm out regardless of price.
The +21% doesn't change this. I discount it for the reason above, but I'm also not using it as support.

Sizing, and what's left of the bull case¶

You're right that the starter is the piece with no evidence. At 25/50/25 it isn't an edge. It's carry (a 2.1% yield) plus exposure to the narrative option. I'm taking your sequencing on size: no more than a quarter of the intended position before the print, sized as loss budget ÷ 0.18, with the rest after the numbers.

What survives is:

The dividend is safe. FY26 FCF would be ~$7.3B even if FQ4 FCF repeated FQ3's $0.5B, and ~$8.3B at $1.5B. Against a ~$3.95B dividend (derived), that's 1.9–2.1x. The buyback is the valve.
The cost step is a decision, not a drift. Decisions can be reversed, and management has signaled it's trying.
The stock is already 31% off its high and 12% off its September high, with no stretch on any tier.

I'm not arguing the print is a good bet. I'm arguing that QCOM is worth owning through a cost reset if the post-print evidence confirms it, and that waiting for that evidence costs about a quarter's dividend.

My question back¶

You say don't initiate. At what price, and on what print, do you start buying? If you can't name a bid, "don't initiate" is a position against the stock, and it needs the same probability weights you asked of me. Bull Analyst: # Bull Rebuttal: My Ceiling Is $187, and Your $198 Gap Is Above It

You're right that without a ceiling my plan had a floor and no top. I've set one below, using your own method so you can check it.

What I'm conceding¶

The success case is a $7-8 EPS story, not $10.19. On your bridge, $8.4B of operating income gives ~$7.1 at 90% conversion and ~$7.9 at 100%. The ratio isn't stable: FQ3 FY26 was 123%, 9M FY25 was 92% and FQ1 FY26 was 89%. That puts a GAAP-like P/E at ~23-25x. The 17.5x sits on a basis neither of us can bridge, since the tools don't size the add-backs, so I'm done using it as a cushion. I can't call 23-25x expensive without a historical or peer benchmark, but I won't call it cheap.
Every bull-zone row means "no further deterioration." Agreed, and that has been my claim.
The February opex test must exclude restructuring charges as management discloses them. If the release gives no ex-charge figure, I score it a miss.
"Not stretched" described $178 and nothing else. $198 is above the upper Bollinger band (195.54), about +2.3σ on standard-band math. At that price the phrase stops applying.

The ceiling¶

I used your method: ~$8B run-rate FCF (OCF $2.5B less ~$0.5B capex), ~1.068B shares and the report's derived net debt of ~$10.8B.

Price	FCF yield	EV/EBIT ($8.4B)	Bull print
$170	4.4%	~22.9x	Your buy level
$178	4.2%	~24.0x	Today: hold starter
$187	4.0%	~25.1x	My last add
$198	3.8%	~26.5x	No add

Your "about 25x" at $198 is ~26.5x on your own EV. The 25x level is $187, and both screens agree there.

Add ceiling: $187 on stabilization-only evidence.
Savings move it. Each $0.5B of quantified annualized savings lifts the ceiling by ~$12 at a 4.0% yield. That is pre-tax and therefore an upper bound, since the tools give no tax rate. A credible $0.5B plan gets the ceiling to ~$199. Without one, a gap to $198 is above it.
I pay nothing for the hyperscaler or SpaceX option. It isn't in the ceiling.
If the stock gaps to $198, I hold the starter and add only on a retrace to $187 or below. Above ~$200 without more evidence, I trim even on a bull print.

Where your table has a problem¶

It buys a good print only if the market rejects it. On your reaction model, a bull print is a +11% gap. Your "buy at ≤$170" row fills only if the stock then falls ~14% from $198. That is coherent if you think $178 already prices the bull print, but it's a valuation view and not a "wait for confirmation" stance.

$178 sits between our values for the same case. You value stabilization at 4.4% (~$170) and I value it at 4.0% (~$187). That is a ~10% disagreement over a yield threshold, and neither of us has a benchmark for it, since you called your thresholds judgment. This is why the starter is a coin flip, and I won't defend it harder than that.

The opex series skips a quarter¶

Your four "consecutive" intervals (-$38M, +$83M, +$69M, +$263M) leave out FQ3 FY25 to FQ1 FY26, because FQ4 FY25 isn't in the tools. You supplied the bridge last round. If the vendor's 18.5% margin is TTM-consistent, FQ4 FY25 operating income was ~$0.85B. At your ~55% gross margin assumption, opex was ~$5.3B, which makes the FQ4 to FQ1 interval about -$2.0B.

Either you keep that derived quarter and the base rate for a down-step isn't -$38M, or you drop it and your YoY caveat goes too. I'm not claiming this shows cost discipline. It probably shows one-off items in the line. That makes reported opex lumpy, and a -$156M move isn't unprecedented. It also means a miss at ≥$3.7B could come from a charge. The lumpiness is why I put the bull zone at 20% and not higher, and why the ex-charge rule matters.

Where we landed¶

	Agreed	Still apart
Pre-print size	No more than a quarter of the intended position	I hold a starter, you don't
Tests	Dollar levels, ex-charges, February time stop
Value of stabilization		You ~$170 (4.4%), me ~$187 (4.0%)
Print odds	Middle bucket ~50%	25/50/25 vs. 20/50/30, expected move ~0 vs. ~-1%, inside both error bars

My position is a small starter, a hard add ceiling at $187 (about $199 with quantified savings), a trim line near $200 and a February exam on cost. The dividend is covered, the cost step is a decision that can be reversed and the print is a coin flip. If that isn't worth owning at $178, I understand. But it's a disagreement over a 0.4-point yield threshold, not a case against owning QCOM. Bull Analyst: # Bull Closing: The Price Is the Middle Print, Not the Success Case

Three of your points land, so I'll take them first. Then I'll show that your central inference, that $178 is the price of the success case, doesn't follow from our own numbers.

What I'm conceding¶

SBC. The tools show no stock-based compensation line, so FCF is before an expense neither of us can size. My $187 ceiling therefore rests on one screen, 25x EV/EBIT, with no peer or historical benchmark. Operating income is after SBC, so I'll lean on that screen.
The $198 add leg is empty, and that's the design. A ceiling that never says no isn't a ceiling. Your plan says "wait and accept I may never fill" in the same scenario.
The carry argument only works after the print. The dividend dates aren't in the tools. If the ex-date falls after the early-November print, waiting forfeits nothing.
A one-off reversing isn't a cut. The roughly -$2.0B step from FQ4 FY25 to FQ1 FY26 shows lumpiness, not discipline. Your base-rate count is off, though. If you keep the derived quarter, there are six intervals and two declines, not one of five. Only one decline is a clean run-rate observation (-$38M), which is why I keep the bull-zone cost odds at 20%.
The YoY headline will flatter every bucket. I agree. It's also why my rule is to trim a pop of more than 8% on a middle print.

Where the midpoint argument fails¶

You said $178.50 is the midpoint of our $170 and $187 values, so the stock is "trading on the success case, with nothing discounted for the middle bucket." That depends on a yield threshold neither of us can benchmark. I tested it with your own zone definitions.

Assumptions (mine): $10.6B quarterly revenue, constant 25.1x EV/EBIT, ~$10.8B net debt, ~1.068B shares	Run-rate EBIT	Per share	vs. $178.28
Bull: opex $3.5B, GM 53.1%	~$8.4B	~$187	+5%
Middle: opex $3.6B, GM 52.9%	~$8.0B	~$178	0%
Bear: opex $3.7B, GM 52.4%	~$7.4B	~$164	-8%

The middle print is worth about today's price. Our zones are narrow, and the whole bull-to-middle gap is about $0.4B of EBIT. At my multiple, $178 prices the middle, not the success case.
Probability-weighted value is $175–176. That is 25/50/25 giving ~$176.4 and 20/50/30 giving ~$175.2, or 1–2% below the price. That is inside both our error bars, and it's why I call the position quarter-size.
At your 4.4% threshold the stock sits above even the bull case. That is a coherent view, but it's a view about a threshold, not a finding.

The "two models" dilemma mostly dissolves¶

You argued that either price follows the P&L, so $178 is already the success value, or it doesn't, so the scoreboard can't time adds. The table above shows the P&L rows justify only about ±6–7% around the middle ($187 vs. $164). The ±11% reaction model is larger. The remainder would have to come from the rows we added: the FQ1 FY27 guide, quantified savings and AI commentary. So the models are not in conflict. The Feb 5 and Apr 24 moves are the residual I can't explain, which is why I pay nothing for the hyperscaler or SpaceX option.

What the starter costs and buys¶

Cost: expected value of -1% to -2% before the guide and savings rows, times a quarter-size position, is roughly 0.4% of the intended position.
What it buys: the one row the tools can't bound from above. Each $0.5B of quantified annual savings adds about $12 per share. At your $280K-per-head figure, that is about 1,800 jobs, or 3.5% of staff. No figures means the middle bucket, which is already priced.
Rough arithmetic: a 25% chance of a $0.5B plan, a guess and not data, is worth about +$3. That roughly offsets the -$2 to -$3 shortfall. It is also unnetted for savings recycled into AI spend.

So the starter is not an edge. It is a roughly zero-expected-value, positively skewed option on the cost plan, held at a size where a gap costs about 4.5% of the intended position. If you read that as too small to argue over, I agree.

Final plan¶

Situation	Bull plan
Pre-print and pre-FOMC (Oct 29)	At most a quarter-size starter, sized for an 18% gap. Review on a close below 168.
Bull print (guide ≥ $11.8B, OCF ≥ $2.5B, opex ≤ ~$3.5B ex-charges)	Add on a retrace. Ceiling is $187, or about $199 with quantified savings. Trim above ~$200.
Middle print	No add. Keep the starter only if the stock closes above 168 and the guide isn't in the bear zone.
Bear print	Cut.
February (first quarter with layoffs live)	Ex-charge opex near $3.5B, or I'm out regardless of price.

Where this leaves us¶

We agree on the facts: stabilization at a lower level is the best outcome the tools can show, the dividend is covered, and the tests are dollar levels ex-charges. What's left is a ~10% disagreement over a yield threshold neither of us can anchor. One lookup of QCOM's historical or peer FCF yield would settle it, and the tools don't have it. That is a reason to size for ignorance, not to hold at zero.

You'd rather pay for the evidence than for the hope that the print supplies it. I accept that as a valid risk preference. But my case isn't hope. It is that the price already assumes roughly the middle print, the cost step is a reversible decision, and the one unbounded row is cheap to hold at quarter size. If the February opex test fails, I'm out.

Bear Researcher¶

Bear Analyst: # Bear Case for QCOM: The Bull's Own Scorecard Is the Problem

You asked two direct questions, so I'll answer them. First, credit where it's due. Your cost-split arithmetic checks out: the $655M cost increase is about 58% of the $1.14B operating income drop. The balance sheet isn't a solvency story, and the insider selling is low-information. I'm not arguing QCOM is broken. I'm arguing that every line you said you'd anchor on is deteriorating, and a 17.5x multiple doesn't reflect that.

1. This is a trend, not a patch¶

	FQ1 FY26	FQ2 FY26	FQ3 FY26
Revenue YoY	+5.0%	-3.5%	-4.0%
Gross margin	54.6%	53.8%	53.1%
Operating income YoY	-5%	-26%	-41%
Operating margin	27.5%	21.8%	16.3%
Implied opex YoY	+12%	+16%	+22%
Operating cash flow ($M)	4,965	2,449	991
FCF ($M)	4,416	1,916	495

Timing noise zigzags. This table shows three consecutive steps in the same direction on every line. Your "nine-month revenue is flat" point is also flattered by the record FQ1. FQ3 revenue sits 18.8% below FQ1, versus about 11% and 5.5% in the prior two years, so the drop is larger than seasonal.

2. Why costs won't normalize¶

Costs are accelerating. A one-off charge fades. +12%, +16% and +22% in three straight quarters compounds.
You're arguing both sides. You call opex "discretionary and controllable," then cite doubled capex as a sign of confidence. If the AI pivot is the strategy, the elevated spend is the plan, not an aberration. The news ties the layoffs to that pivot, which means reallocation. There is no headcount and no savings figure.
The catalyst can't prove your thesis. The fiscal year ends in late September, and the layoffs start in November. The early-November print can't show any savings. Severance would typically land first (my inference), so at best you get a promise.
The scale doesn't fit. $655M a quarter is about $2.6B annualized. "Performance-based" trimming at a 52,000-person company doesn't obviously close that.
Gross profit is shrinking too. Even your flat-cost counterfactual has FQ3 operating income down 17%, because gross profit fell $481M and gross margin has dropped three quarters running.

The tools don't say what is inside the cost line, and I'm not claiming to know. But the burden sits with the side claiming it's temporary, and no data shows it stabilizing.

3. Why FQ3 cash isn't "timing"¶

It's operating cash flow, not capex. OCF fell 66%, from $2,875M to $991M. Capex rose $202M, which explains only about 10% of the $2.09B FCF drop. Doubled capex can't be the cause, and it isn't reassuring when OCF is collapsing.
Conversion halved. OCF was 108% of net income in FQ3 FY25 and 50% in FQ3 FY26.
It ratchets down. Timing effects reverse. OCF fell 51% sequentially, then another 60%.
The dividend wasn't covered in FQ3. FQ3 FCF of about $0.5B compares with a roughly $1.0B quarterly dividend (derived), about 0.5x. Your 2.3x is a nine-month figure propped up by FQ1's $4.4B. Financing outflows averaged about $3.3B a quarter.
The liquidity argument cuts both ways. You say marketable securities are missing from the tools, so liquidity is understated. The tools also show no debt line. D/E of 55% implies about $15B of debt against $4.5B of cash, and current liabilities are up 46% in a year with the mix unknown. Equity of $27.7B includes a roughly $5B non-operating gain. Strip that out and liabilities-to-equity is about 1.3x (my rough arithmetic), not 1.07x.

Either buybacks slow or leverage rises. Neither supports a $10.19 forward EPS.

4. "Priced for pessimism" doesn't match the price¶

The multiple is shaky. You concede the $10.19 is probably non-GAAP and not like-for-like, then lean on 17.5x and a 0.78 PEG anyway. That PEG implies about 22% growth (17.5 ÷ 0.78) from a company with shrinking revenue. The tools also give no peer or historical multiple, so "cheap" has no benchmark.
It's not cheap on operating income. Nine-month operating income annualizes to about $9.7B, which is roughly 20x market cap. At the FQ3 run rate it's about 29x. Rough EV/EBITDA is about 17x for a business with falling revenue.
The price has run ahead of profits. The stock is 45% above its April low and 21% above its July low, while FQ2 and FQ3 operating income fell 26% and 41%.
Your own tape data shows no pessimism. Z-score is 0.00 weekly and -0.30 daily, and RSI is 50. "Neither chased nor panic-sold" describes a fairly priced stock, not a washed-out one.
The analyst target says the same. Susquehanna's $185 is +4%, and the old $160 target sat below the market. That is catching up to the price, not a conviction call.

5. Your risk/reward math is mis-specified¶

The upside is anchored to a spike. Your 40% target is the May close of $248.74. You admit the tools don't explain that spike, and it fully reversed, down 41% to $146.81 by July 31.
The downside is a moving average, not a floor. The 200 SMA is 5.7% away. A revisit of the July close is -18%, and the April close is -31%.
One bad day gets you there. ATR is 3.9% of price. The data show one-day moves of -8.5% (Feb 5), -7.2% (Sep 28) and -5.8% on 54.5M shares (Sep 18). With beta at 1.65, an FQ4 print around Nov 4 (unverified) plus a Fed meeting on Oct 29 can reach your "downside" in a session.

6. The tape, flows and macro¶

Lagging indicators only count when they're bullish. You dismiss the weekly SuperTrend as lagging, but your MA stack is just as lagging. Weekly and daily SuperTrend are both DOWN, MACD is below zero and below its signal, OBV is 556M against a 606M peak, and the averages are compressed. The 200 SMA "support" is one touch, as you conceded. The 10-21 bar is also partial, so RSI, MACD and OBV are provisional.
The ETF flow is noise. $121.4M is about 0.06% of a $190B market cap.
Retail isn't a tailwind. StockTwits confidence is low, and the 7:1 bullish label ratio is mostly mislabeled or off-topic posts. The unlabeled posts say "CEO totally unable to inspire." Bored holders aren't a catalyst.
The macro is "higher for longer," not a tailwind. The Fed debate is hold versus a 14% hike risk, with about 0% odds of a cut and 97% odds of no cuts in 2026. The macro report says that weighs on tech multiples. The FRED data (CPI, 10-year, VIX) failed to load, so "calm" is partly unverified. Tariff and export-control risk for a China-exposed handset name is unquantified.
Arm is unquantified. "Negotiated status quo" is as much an inference from one headline as anything I'd say. A judge declining to intervene leaves a legal overhang with no resolution and no price tag.

7. Your tripwires are already near-tripped¶

You said you'd turn cautious if gross margin fell below about 53%, opex growth stayed near 20%, FCF didn't rebound, or the stock closed below 168.

Gross margin is 53.1%, falling 0.7–0.8 points a quarter. Extrapolating gives about 52.4%.
Opex growth is 22% and accelerating.
FCF has no rebound and fell to $495M.
168 is about 1.5 ATR away.

Your failure conditions are the trend-continuation case. The question for the print isn't whether things get worse, but whether anything reverses, and nothing in the data shows that.

Bottom line¶

I'm not calling a collapse. I'm saying a business with falling revenue, three quarters of shrinking margins and a halving of cash conversion shouldn't be bought on a non-comparable forward EPS. The stock is already 45% off its April low, and the risk/reward into a Fed meeting and an earnings print is worse than 40% up versus 6% down.

I'd change my mind on: - gross margin holding at 53% or better, - opex growth below roughly 10%, - OCF back toward $2.5B or more, - a quantified cost-savings plan with an explanation of the FQ3 cash drop.

Can you point to a single data point in the tools showing the cost line or cash flow has stopped deteriorating? Bear Analyst: # Bear Rebuttal: Stabilization Isn't a Buy

You've been straight about what the tools can and can't show, so I'll fix what you got right, then answer your question.

What I'm dropping¶

The 1.3x leverage figure. You're right that it stripped the FQ2 gain but left the FQ4 FY25 loss in the base. Liabilities-to-equity moved from 1.02x to 1.07x. Cash at $4.5B and the unexplained 46% rise in current liabilities stay on the diligence list, but they aren't a thesis.
"Compounding" opex. The dollar view is better than my YoY table. Sequential steps of +$70M and then +$263M are decisions, not drift.
Cash conversion. Nine-month OCF/operating income of 115% is fine, and FQ1 was an outlier. "OCF down 16% over nine months" is fairer than quoting FQ3 alone.
Payoff math. Ratios of 1.4–2.3x need only a 30–42% hit rate to break even. My objection is to how you paired the levels and to the missing probabilities.

Which print is likelier? The calendar cuts against you¶

Savings can't show up in this print. FQ4 covers July–September, and the layoffs start in November, which is FQ1 FY27. Your $3.5B opex bar needs a ~$155M sequential drop with no cuts yet in effect. Severance, if anything, lands later (my inference).
The modal outcome is the middle. Opex lands between $3.5B and $3.7B, with neither scoreboard confirmed. My judgment, not data, is that all three bull conditions hit together about one time in five.
Beware mechanical improvement. Derived FQ4 FY25 revenue (~$11.3B) was 8.7% above FQ3 FY25. A sequential rebound in operating income or OCF may just be seasonality, so judge it year over year.

Even your success case is a smaller P&L¶

At FQ3 revenue and 53.1% gross margin	FQ3 FY25	FQ3 FY26	Your "bull confirmed"
Opex	~$3.00B	~$3.66B	$3.50B
Operating income	$2.76B	$1.63B	~$1.78B
vs. FQ3 FY25		−41%	−36%

That annualizes to ~$7.1B of operating income, or ~27x market cap. The same holds for cash. TTM FCF of $10.24B minus nine-month FCF of $6.83B implies a derived FQ4 FY25 FCF of ~$3.4B. Your OCF bar of $2.5B, less ~$0.5B capex, is ~$2.0B of FCF, about 40% lower year over year.

Hitting your scoreboard means "stopped getting worse at a lower level." That's a legitimate outcome, but it isn't a "reset price" story.

The opex steps only go up¶

No step down yet. Implied opex went from ~$2.9B in FQ2 FY25 to ~$3.7B now, and no observed interval declined.
Opex vs. revenue. Opex is 36.8% of revenue, versus 29.0% a year ago.
Layoff scale. Annualized FQ3 opex over ~52,000 employees is ~$280K per head all-in (rough, includes non-people costs). Offsetting the $655M quarterly YoY increase would take ~9,400 jobs, about 18% of staff. Nothing in the news points to that scale.
Your bar is lower. Your $3.5B level needs only ~2,200 jobs, about 4%. I'll grant a "performance-based" cut can deliver that, but in FQ1–FQ2 FY27, not in this print. And an "AI pivot" implies some savings get recycled.

178 already assumes better than trend¶

You argued that my downside needs a print worse than the trend anyone can draw. It doesn't.

The price moved with no new data. The stock is +21% from the July 31 close of 146.81, which came days after the June-quarter report (inferred from the late-July event cluster). Since then, the tools show only a layoff memo and a +4% price-target move.
The forward EPS embeds a recovery. Forward EPS of $10.19 is ~36% above the FQ3 GAAP run rate ($1.87 × 4 = $7.48). Part of that gap is non-GAAP add-backs of unknown size, but you can't call the basis non-comparable and also use 17.5x as a cushion.
The spring surge is unexplained. The stock went from 132.73 to 248.74 (+87%) with operating income falling. If the price doesn't trade on the P&L, as you say, then 178 isn't anchored to anything I can verify.

So my downside only needs the print to fall short of what's already priced.

Risk/reward, paired like with like¶

Upside levels aren't targets. 194.48 and 223.47 are trailing-stop flip levels. Using them as targets against a 200 SMA downside mixes two kinds of level.
Event moves are about ±10%. The two inferred earnings reactions were −8.5% and +11%, which map to ~160 and ~196. The 200 SMA at 168 sits inside one ordinary event move, so it isn't a stop.
The payoff is roughly symmetric. Any edge comes from probability, and you haven't offered one.
Stacked macro risk. The Oct 29 FOMC (14% hike tail) lands about six days before the print, on a beta-1.65 name.

Your plan is to add only on evidence from the print. That makes the starter position the one piece with no evidence behind it.

Do I flip?¶

On the narrow claim, yes. If opex is ≤ ~$3.5B, gross margin ≥ 53% and OCF ≥ $2.5B, I retire "still deteriorating." That isn't a new bar, it's a different question. Whether stabilization at ~36% lower operating income is worth ~$178 depends on the FQ1 FY27 guide and quantified savings, and neither is in the tools.

My stance is not to initiate ahead of the FOMC and the print, and to revisit on the numbers. If you're already holding, size for a gap, as you said.

My questions back¶

What probabilities do you put on the bull, middle and bear buckets of your own scoreboard?
Suppose opex is $3.6B, gross margin 52.9%, OCF ~$2.0B and no savings figure. That is a middle print, with the cost-plan row bear-confirmed. What do you do with the starter after a stock that's already +21% since the last report? Bear Analyst: # Bear Rebuttal: A Bid, a Probability, and How Little Separates Us

You asked for a bid and odds, and that's fair. First, what I'm giving up.

What I'm conceding¶

Opex fell once. FQ1 to FQ2 FY25 was down about $38M (my arithmetic: $2,956M to $2,918M). I'm retiring "no interval declined."
27x annualized the seasonal trough. Your success case is about 23x pre-tax. I accept that.
The stock de-rated from $201.97, down 11.7%. It did not run into the print.
Judge the print in dollar levels, not YoY. If the vendor's 18.5% margin is TTM-consistent, FQ4 FY25 operating income was only about $0.85B. With gross margin around 55% (my assumption), that points to roughly $2B of unexplained cost above run rate. In that case the September-quarter YoY operating income will look like a huge gain whatever it says about stabilization.

Your own series still cuts my way¶

The four consecutive intervals we can observe are about -$38M, +$83M, +$69M and +$263M. Your bull zone (≤$3.5B) needs a ~$156M sequential drop, four times the only decline in the data, in a quarter where no layoff savings can appear. The one case you cite as proof that opex is a policy variable shows management holding it flat through an 11% revenue decline, not cutting it.

On the cost line, which your thesis hangs on, your own odds are 20% bull zone against 35% bear zone.

Your success case still isn't the EPS behind 17.5x¶

Bull-confirmed run rate	Value
Operating income	~$8.4B (your figure)
EV / EBIT (EV ≈ $201B, debt derived)	~24x
Net income at ~90% of operating income (9M FY25: 92%, FQ1 FY26: 89%)	~$7.6B
EPS on ~1.068B shares	~$7.1
P/E at $178.28	~25x

That is about 30% below the $10.19 forward EPS. The bridge is probably non-GAAP add-backs, which the tools can't size. FQ3's net income was 123% of operating income, so below-the-line items can help, but nobody can see why. Confirming your scoreboard gets you to roughly $7 of EPS, not $10.

Two scoreboard fixes: - Revenue. Your bull-zone guide of -4% YoY is the current trend (-3.5%, -4.0%). Every bull-zone row means "no further deterioration," which is the narrow claim I already accepted. - Severance. It likely lands in FQ1 FY27 (my inference). The February time stop on opex needs a number excluding charges, and the tools won't provide one.

Probabilities and the bid¶

My buckets are Bull 20 / Middle 50 / Bear 30, because of your own cost-line odds and the lack of savings in the quarter. Using your ±11% reactions, the expected move is about -1% against your 0%. That difference is inside both our error bars, so "don't initiate" is not a forecast of a drop.

Situation	Action
Pre-print	Resting bid only at ~$150, near the July 31 close of 146.81, the last price set with FQ3 known and no spring-surge froth. Fill odds before the (unverified) Nov 4 print are about 5%, from ATR arithmetic. That bid is deliberately far away.
Bull bucket, guide ≥ $11.8B, quantified savings	Buy the first third at ≤ ~$170. If it gaps toward ~$198, I wait for a retest and don't chase.
Middle print	No buy above ~$155
Bear print	No bid above the July close, then reassess

The price logic is FCF yield on your success case (OCF $2.5B less ~$0.5B capex, so about $8B a year). That is 4.2% at $178, 4.4% at $170 and 5.0% at $150. The yield thresholds are my judgment, since the tools give no historical or peer yield.

What the remaining disagreement is worth¶

Take your quarter-size starter and our two odds sets: - Missed gain if I wait: 25% × 11% × 0.25 ≈ 0.7% of the intended position. - Avoided loss if I wait: 30% × 11% × 0.25 ≈ 0.8% of the intended position.

Both sit well inside the error bars. Waiting costs about $0.93 a quarter in dividend (derived), and the ex-date isn't in the tools. If it falls after Nov 4, waiting forgoes none of it. We've converged on shape: no pre-print size, and add only on evidence. We differ on whether a quarter-size starter earns its variance, and at that size I won't defend the point hard.

What's left¶

The real gap is the price paid for stabilization, and the narrative option you concede is outside the P&L. That narrative took the stock from 132.73 to 248.74 (+87%) and then fully reversed by July. The hyperscaler and SpaceX talk is unconfirmed even by its own poster. I agree with your two guide and AI-commentary rows. I treat the option as a source of volatility I can't underwrite, not a free kicker.

Question back¶

Name your ceiling. Suppose the bull print arrives, the guide is ≥ $11.8B, savings are quantified and the stock gaps to ~$198. That is about 25x EBIT and about 3.8% FCF yield on your own run-rate. Do you add there, or does "not stretched" stop applying? If you can't name that price, your plan has a floor and no ceiling, which is the same flaw you found in my bid. Bear Analyst: # Bear Closing: $178 Is the Price of the Success Case

Your ceiling table is sound, and it points to where we still differ. Corrections first.

What I'm conceding¶

$198 is ~26.5x EBIT, not "about 25x." Using ~1.068B shares and $10.8B net debt, I get your 22.9x / 24.0x / 25.1x / 26.5x ladder.
Your ceiling method is internally consistent. Capitalizing ~$8B of FCF at 4.0% gives $187, and $0.5B of quantified savings adds ~$12 (pre-tax, so an upper bound). I won't argue your yield threshold. I have no benchmark for mine either.
"Four consecutive intervals" skipped a quarter. If the vendor's 18.5% margin is TTM-consistent, FQ4 FY25 operating income was ~$0.85B. At my assumed 55% gross margin, opex was ~$5.35B, so the FQ4-to-FQ1 interval is about -$2.0B. I'll keep the derived quarter.
My table is a valuation view, not a "wait for confirmation" stance. It says $178 already prices the good print. I own that.
The starter doesn't need more defense. It is a quarter-size position and the expected edge is inside both our error bars.

$178 sits at the midpoint of our two values for the same case¶

You value stabilization at ~$187 and I value it at ~$170. The midpoint is $178.50. That means the stock isn't trading on a probability-weighted print. It's trading on the success case, with nothing discounted for the 50% middle bucket or the 25–30% bear bucket.

You call the gap "0.4 points of yield." It's $17 a share, or 10%. That is about 2.5 ATRs and the same size as the ±11% earnings move we've both used. On a stock with this much volatility, that disagreement is the whole trade, whichever side you take.

Your add leg is mostly empty¶

On a bull print, your reaction model gives ~$198:

Evidence	Your ceiling	Action at $198
Stabilization only	$187	No add
Plus ~$0.5B quantified savings (~1,800 jobs at the rough $280K per head)	~$199	Add, at your own hurdle with no margin of safety
No further evidence, price above ~$200		Trim

The plan either doesn't add or adds at the price where your method returns exactly your hurdle. You faulted my table for buying a good print only if the market rejects it. Yours buys it only if the market underreacts, or if there is zero cushion.

Two models that don't agree¶

Your expected move of ~0 comes from the reaction model (+11 / 0 / -11). You've said that model doesn't track the P&L: the stock fell 8.5% on a record-revenue FQ1 and gapped +11% on an FQ2 with operating income down 26%. I used the same model for my -1%, so this cuts at both of us.

If the price follows fundamentals, $178 already equals the success-case value. The middle and bear buckets are worth less, so the expected value is below the price.
If the price doesn't follow the P&L, the scoreboard can't tell you when to add. The starter is then a bet on the narrative option you said you won't pay for.

Neither branch gives print-specific evidence for owning before the print.

One caveat on the FCF screen, which we haven't raised: FCF here is OCF less capex. The tools show no stock-based compensation line, so the 4.0% is before an expense I can't size. The EBIT screen already bears it, which is a reason to weight the 25x over the 4.0%.

FQ4 FY25: I accept the arithmetic but not the inference¶

We agree it doesn't show cost discipline. Two consequences follow.

The recurring base still stepped up. FY25 clean quarters ran $2.9–3.0B, and FY26 runs $3.3–3.7B. A one-off reversing is not a recurring cut. The base rate for a run-rate decline is still one of the five observed intervals, at -$38M.
The YoY headline will flatter every bucket. I assume ~$10.6B revenue and, as before, that the vendor margin is TTM-consistent.

FQ4 FY26 case	Gross margin	Opex	Operating income	vs. derived $0.85B
Bull zone	53.1%	$3.5B	~$2.1B	~+150%
Bear zone	52.4%	$3.7B	~$1.85B	~+118%

A headline like "operating income more than doubles" arrives in every bucket. That is another reason to judge in dollars and ex-charges, and it also means severance could make a miss look like a one-off.

Where I land¶

I'm moving one thing. At my 4.4% yield, ~$0.5B of quantified savings is worth ~$10–11 a share, so my post-print buy level rises to ~$181 in that case. That narrows the gap, but it doesn't close it.

Situation	Bear plan
Pre-print and pre-FOMC (Oct 29, 14% hike tail)	No initiation. If holding, keep it to a quarter-size position or less, sized for an 18% gap, with a close below 168 as a review point.
Bull print (guide ≥ $11.8B, OCF ≥ $2.5B, opex ≤ ~$3.5B ex-charges, quantified savings)	Buy the first third at ≤ ~$181 or ≤ $170 without savings. If the stock gaps to $198, I wait and accept I may never fill.
Middle print	No buy above ~$155
Bear print	No bid above the July close (~$147), then reassess
February	The first quarter with the layoffs live. Opex ex-charges must be near $3.5B.

If I'm wrong and the stock never retraces, I miss a position whose total expected edge we both put inside our error bars. If you're wrong, the loss is an 18% gap on a stock you bought at the price of its success case.

The closing disagreement¶

We agree on the facts: stabilization at a lower level is the best outcome the data can show, and the dividend is covered. We differ on one point: whether to pay for that outcome at $178 before seeing it. I'd rather pay for the evidence than for the hope that the print supplies it. Bear Analyst: # Bear Closing: At $178 You're Paying Your Own Ceiling Multiple for the Middle Print

Your closing is the best-constructed version of the bull case so far, and it moves me on two points. Then I'll show where the remaining gap sits.

What I'm conceding¶

"Success-case price" was too strong. At 25.1x EV/EBIT, $178 values your middle print, not your bull print. I withdraw the claim.
The interval count. Six intervals with two declines is right as a raw count. I net it below.
Neither yield threshold is benchmarked. I won't defend 4.4% as more than a judgment.
The weighted shortfall is 1–2%, which is inside both our error bars. My case doesn't rest on forecasting a drop.
The empty $198 add leg is by design. We agree on that.

1. Your ceiling multiple is the market's multiple on the middle print¶

EV today is about $201.2B (the $190.4B market cap plus your derived $10.8B net debt). On your middle-case EBIT of about $8.0B, that is 25.05x. You set 25.1x as the most you would pay for the best realistic print. Using your table:

Case	Run-rate EBIT	Value at 25.1x (yours)	Value at 22.9x (my $170 bull equivalent)
Bull	~$8.4B	~$187	~$170
Middle	~$8.0B	~$178	~$162
Bear	~$7.4B	~$164	~$149
Weighted (25/50/25 or 20/50/30)		~$176	~$160–161

On your own weights, the starter breaks even at about 25.3x, which is above your own ceiling multiple. At any multiple at or below your ceiling, expected value is negative. "Priced for the middle" is true, but it is priced at the most generous multiple you've named, with no margin of safety for the 25–30% bear bucket. That is also why I read your "reversible cost step" as already paid for, not as an option.

2. Your option is priced from one side¶

You offset the roughly -$2 to -$3 shortfall with +$3, which is 25% times about $12 of savings per $0.5B. Three problems:

The $12 is an upper bound. You said it is pre-tax and unnetted for savings recycled into AI spend and for severance.
The 25% is a guess, as you said.
You priced only the upside of the new rows. Your bull-zone guide (≥ ~$11.8B, no worse than -4%) is the baseline already in your $10.6B revenue assumption, so it adds no upside. Its bear zone (< ~$11.3B, about -8%) is another ~4% of revenue. My rough arithmetic: 4% × $10.6B × 53.1% × 4 is about $0.9B of EBIT, or ~$21 a share at 25.1x. Even at only a 25% chance (borrowed from your bear bucket), that is about -$5, against +$3.

On a symmetric count, the starter is mildly negative on the numbers, not zero-EV with a positive skew. I'd grant it is small, not that it is skewed in your favor.

3. The interval count, netted¶

You're right that with the derived FQ4 FY25 quarter there are six intervals and two declines. Here they are:

Interval	Change in implied opex
FQ1 → FQ2 FY25	-$38M
FQ2 → FQ3 FY25	+$83M
FQ3 FY25 → FQ4 FY25 (derived)	~+$2.35B
FQ4 FY25 → FQ1 FY26 (derived)	~-$2.03B
FQ1 → FQ2 FY26	+$69M
FQ2 → FQ3 FY26	+$263M

The second decline only reverses the up-step the quarter before it. Across those two quarters the net is about +$320M (~$3.00B to ~$3.32B). Treated as one two-quarter interval, there are five run-rate intervals and one decline, which is what I said. The derived quarter shows lumpiness. It doesn't show a cut. Your 20% bull-zone cost odds already reflect that.

4. "Size for ignorance" argues for looking first¶

You say one lookup of QCOM's historical or peer yield would settle the ~10% gap, and the tools don't have it. A portfolio manager can do that lookup today. Not knowing a parameter you can look up in an afternoon is a reason to look it up before taking risk. Taking risk because of it doesn't follow. Waiting also looks cheap on your own numbers:

Missed gain versus avoided loss. My earlier arithmetic put these at about 0.7% and 0.8% of the intended position, which is a wash.
The dividend. The tools show the regular dividend was announced this week but give no record date. My recollection, not in the tools and worth verifying, is that past October declarations have set early-December record dates. If so, waiting forfeits nothing.
Information. The print, which is unverified but likely around Nov 4, resolves more than any lookup, and before it comes the Oct 29 FOMC with its 14% hike tail on a beta-1.65 stock.

Where each plan stands¶

	Bull plan (yours)	Bear plan (mine)
Pre-print	Quarter-size starter at most, review below 168	No initiation. If already holding, quarter-size at most.
Bull print	Add only on a retrace to ≤ $187, or ~$199 with quantified savings	Buy the first third at ≤ ~$170, or ≤ ~$181 with quantified savings
Middle print	Hold the starter if it closes above 168 and the guide isn't bearish	No buy above ~$155
Bear print	Cut	No bid above ~$147
February	Ex-charge opex near $3.5B, or out	Same test

On a gap to $198, neither of us buys. So the plans differ mostly on the starter and the post-print entry price, and both rest on the same unbenchmarked multiple.

What stays on the table¶

I'm not claiming QCOM breaks. These items remain unresolved:

The weekly SuperTrend is DOWN, with a flip level of 223.47.
The 200 SMA at 168 is one touch, not validated support.
The Arm overhang is unquantified, and so is tariff and export-control exposure for a China-exposed handset name.
Several inputs are missing: FRED macro data, segment data, guidance, and the composition of the opex step.

What would change my mind¶

I'd lift my ceiling and take the starter before the print only if the multiple lookup shows QCOM has typically traded at or above ~25x EV/EBIT (or at or below a ~4.0% FCF yield) in similar growth regimes. That would make your 25.3x break-even a normal multiple, not a generous one. After the print, I'd buy on the levels in the table.

Bottom line¶

We agree on the facts. Stabilization at a lower level is the best outcome the data can show, the dividend is covered, and the tests are dollar levels ex-charges. We differ on one decision: whether to own QCOM at 25x EBIT on the middle print before the evidence arrives. On your own table, the starter breaks even only at your ceiling multiple, and a lookup you can do now would settle the multiple. I'd wait for the print.

Research Manager¶

Recommendation: Underweight

Rationale: This came down to valuation arithmetic more than narrative. The bear won it, but not decisively. On the facts, both sides converged. Every operating line deteriorated for three straight quarters. Operating margin went 27.5% to 21.8% to 16.3%. Gross margin slid from 54.6% to 53.1%. Implied opex rose +12%, +16% and +22% YoY to about $3.66B. Operating cash flow fell from $4.97B to $2.45B to $0.99B. When the bear asked for one data point showing a turn, the bull said honestly that there isn't one.

The bull's best points held up. Nine-month OCF-to-operating-income conversion is about 115%. The dividend is covered about 1.9-2.1x on FY26 FCF even if FQ4 is weak. Liabilities-to-equity is only 1.07x. The opex step looks like a reversible management decision, not drift. The stock has already de-rated 11.7% from its September high, and nothing is technically stretched. That is why this is not a Sell.

Four things decided it: - The 17.5x forward P/E doesn't hold. It rests on a $10.19 EPS neither side could bridge to GAAP. Even the bull's success case is roughly $7-8 of EPS, a 23-25x GAAP P/E and about 24x EV/EBIT. The bull retired the word cheap. - The bull's own table works against him. At $178, the stock prices the middle print at 25.1x EV/EBIT, which is the ceiling multiple the bull set for the best realistic print. Probability-weighted value is about $175-176 at that multiple and about $160 at the bear's. A pre-print starter only breaks even at about 25.3x, above the bull's own ceiling. - The option was priced from one side. Quantified savings are worth maybe +$3 a share in expectation. A bear-zone FQ1 FY27 guide, against a record $12.25B comp, is worth roughly -$5. - The calendar is against the bull. Layoffs start in November, so the early-November print (date unverified) cannot show savings. The bull's own odds put the cost line at only 20% bull-zone versus 35% bear-zone. It all sits behind an Oct 29 FOMC with a 14% hike tail, on a 1.65-beta stock with a 3.9% ATR.

The weighted shortfall is only 1-2% at the bull's multiple, and the balance sheet is sound. Both analysts independently landed on no more than a quarter-size position before the print. The bear's point that today's price already pays a full multiple for an unconfirmed middle outcome is the stronger argument. So: trim, don't exit, and rebuild on evidence at defined prices.

Gaps to flag: - No historical or peer multiple. This is the one lookup that would settle the 4.0% vs 4.4% FCF-yield and ~25x EV/EBIT dispute. - No stock-based-compensation line. - No opex composition or segment data. - Missing FRED macro data. - Arm litigation and China or export-control exposure are unquantified. - The earnings date and dividend record date are unverified.

Strategic Actions: 1) Trim to roughly 25% of a standard allocation before the Oct 29 FOMC and the early-November FQ4 print. New money should not initiate before the print. If a mandate requires exposure, cap it at a quarter-size starter.

2) Size the remaining position so an 18% gap, back toward the ~$147 July 31 close, stays within the loss budget (position = loss budget / 0.18). Do not rely on 168 as a stop, because roughly 10-11% event moves can skip it. Treat a close below 168 (the 200-day SMA) as a review trigger.

3) Before rebuilding, do the lookup the tools lacked: QCOM's historical and peer EV/EBIT and FCF yield. If QCOM has typically traded at or above ~25x EV/EBIT, or at or below ~4.0% FCF yield, in similar low-growth regimes, move back toward Hold or standard weight on any non-bear print. Also verify the print date and the dividend ex-date and record date. If the record date falls after the print, the trim forfeits no dividend.

4) Score the print in dollar levels, excluding charges, not YoY. The derived FQ4 FY25 base of about $0.85B operating income will make YoY look like a huge gain in every scenario. Also discount seasonality, since FQ4 has run about 8-9% above FQ3. The bull and bear lines are: - Implied opex: at or below ~$3.5B is bull; at or above $3.7B is bear. - Gross margin: at or above 53.0% is bull; below 52.5% is bear. - OCF: at or above $2.5B is bull; below $1.5B is bear. - FQ1 FY27 revenue guide: at or above ~$11.8B is bull; below ~$11.3B is bear. - Cost savings: quantified or not.

5) Bull print (at least two bull-zone lines, none in the bear zone, guide at or above $11.8B): rebuild toward standard weight in thirds. - Buy the first third at or below ~$170 without quantified savings, or at or below ~$181 with about $0.5B of quantified savings. - The hard add ceiling is $187, or about $199 with quantified savings. - Do not chase a gap toward ~$198. Add only on a retrace. - Trim above ~$200 absent new evidence.

6) Middle print: keep the quarter-size position only if the stock closes above 168 and the guide is not in the bear zone. Add only at or below ~$155. Trim into any gap of more than 8%, which the P&L would not justify.

7) Bear print (opex at or above $3.7B with no savings plan, OCF below $1.5B, or guide below $11.3B): exit the remainder. Place no bid above ~$147 and reassess.

8) Time stop at the FQ1 FY27 print (~February), the first quarter with layoffs in effect. Opex excluding charges must be near $3.5B, or exit regardless of price. If no figure excluding charges is disclosed, score it a miss.

9) Monitor Arm litigation and tariff or export-control headlines as unquantified tail risks. Any adverse quantified development should take the position to zero.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The research plan is Underweight, which maps to a Sell sized as a trim rather than a full exit. Three straight quarters of margin and cash-flow deterioration, with no evidence of a turn, sit against a price of 178.28 that already pays about 25x EV/EBIT for an unconfirmed middle outcome. The technicals do not argue against trimming: the weekly and daily SuperTrend are DOWN (flip levels 223.47 and 194.48), MACD is below zero and below its signal, and RSI is a neutral 50, so nothing is oversold. The Oct 29 FOMC and the unverified early-November FQ4 print are near-term event risks that can gap past the 168 level, and the portfolio context is not provided, so the trim is expressed relative to the caller's own position.

Entry Price: 178.28

Stop Loss: 168.0

Position Sizing: Trim to about 25% of a standard allocation before the Oct 29 FOMC and the early-November FQ4 print. Size the remainder so an 18% gap toward the ~147 July 31 close stays within the loss budget (position = loss budget / 0.18). Treat a close below 168 (the 200 SMA at 168.16) as a review trigger, not a hard stop, because roughly 10-11% event moves can skip it. No new money before the print. If a mandate forces exposure, cap it at a quarter-size starter.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: I'll open the debate, since neither of you has spoken yet, and respond to the arguments I expect.

The aggressive move on QCOM today is acting on what the data shows. Sitting at full size into a binary event, hoping the last three quarters were an accident, is the passive choice, and it is a big bet. Operating margin went from 27.5% to 21.8% to 16.3% over three quarters. Free cash flow went from $4.4B to $1.9B to $0.5B. Operating income was down 5%, then 26%, then 41% year over year, and implied operating costs grew 12%, 16%, then 22% while revenue shrank. Nothing in the data shows a turn. Against that, the market pays roughly 25x EV/EBIT on the trailing numbers. On the latest quarter's run rate it is closer to 31x, by my arithmetic. That is a premium for a recovery nobody has confirmed.

I expect the conservative analyst to say the stock sits above its 10 EMA, 50 SMA and 200 SMA, so don't sell. That stack is a product of whipsaw. The stock went 123 to 249 to 147 to 202 and is now at 178, so any average of that path will sit right around the price. The three averages span only about 8.5 points. Meanwhile the weekly and daily SuperTrend are both down, with flip levels at 223.47 and 194.48. The stock needs a 9% rally just to turn the short-term trend. The 200 SMA at 168 is also only 6% below us, while the July close of about 147 is 18% away. The downside gap is bigger than the cushion that the averages suggest.

The conservative case may also cite the 2.1% dividend yield and the Susquehanna raise. The raise takes the target to $185, about 5% upside, which is not a re-rating. ETF buying of $121M is about 0.06% of a $190B market cap, which is noise. The dividend costs about $4B a year, or about $1B a quarter, by my derivation. FQ3 free cash flow was $495M, so the latest quarter covered only about half of it. Over nine months, shareholder returns of $10.0B exceeded free cash flow of $6.8B. I'm not predicting a cut, but the yield is not the safety net it looks like.

I expect the neutral analyst to say the signals are mixed, RSI is 50, the z-score is flat, and we should wait for the print. I agree the technicals don't scream sell, and I said so in the plan. But waiting at full size is not neutral. With a beta of 1.65, this stock has moved roughly 10 to 11% on prior events: the February drop, the April gap and the late-July slide. The FOMC on Oct 29 comes first. The market prices a hold at 86%, a 14% hike tail, and 97% odds of no cuts in 2026, which is a hostile regime for a 25x multiple. Then comes the early-November print, and the date is unverified. The layoffs start in November, after the quarter ended, so the savings won't show up in FQ4 numbers. Guidance and the tax and one-off questions will carry the print, and the thin QCT prediction market, with a few hundred dollars of volume, tells us nothing.

The bullish gap scenario is real, and I'm not hiding from it. That is why this is a trim to about 25% and not a full exit. If QCOM gaps up 11% like it did in April, the remaining quarter position participates and we have cash to act. If it gaps down 10 to 18%, we've avoided most of the damage and have dry powder at better prices. The 168 level is a review trigger, not a hard stop, because gaps skip stops. Sizing the remainder so an 18% fall stays inside your loss budget (position equals budget divided by 0.18) is how you survive being wrong and stay aggressive afterward.

I'll concede the uncertainties. The 10-21 bar is incomplete, I have no segment or guidance data, and the insider selling is programmatic and carries no information, so I'm not leaning on it. The Arm overhang rests on a headline. The case rests on the deteriorating fundamentals, the valuation and the event calendar, and it doesn't need any of those weaker points.

Because I don't know your current holdings, apply the trim to your own position. Take it to about a quarter of a standard allocation, add no new money before the print, and use a quarter-size starter if a mandate forces exposure. The aggressive way to get paid is to be right about the trend and have capital free when the price resets.

FINAL TRANSACTION PROPOSAL: SELL (trim to about 25% of standard size ahead of the Oct 29 FOMC and the early-November FQ4 print) Aggressive Analyst: Let me start with where we stand. All three of us now say sell, add no new money before the print, and size the remainder off a loss budget. The fight is down to whether you walk into the print with a quarter of a standard position or half. I'll take the corrections first, then explain why I still land at a quarter.

You were both right on several things. The Fed isn't carrying weight in my case anymore. The hike tail fell from about a third to 14% in a week, no cuts is already 97% priced, and the print is the event. My EV/EBIT figures were soft, because there are no marketable securities in the data and the FQ3 annualization sits on a seasonal low. The 10 to 11% event moves were really 8.5% down in February and 11% up in April. And "dry powder at better prices" was a bad phrase. A lower price isn't a reason to buy, evidence is.

The valuation point survives the corrections, though. Annualized FQ3 EPS is $7.48. Bump that 6% for seasonality and you get about $7.93, or roughly 22.5x at 178.28. Net income still exceeded operating income in that quarter, so below-the-line items are helping. The 17.5x forward multiple needs $10.19, which is probably non-GAAP and not comparable. The neutral says that's the margin question counted twice. I agree it's the same question, and that's my point: the price already contains an answer to what the print asks.

I also don't think we've weighed this enough. Since the July 31 close of 146.81 the stock is up about 21%, and it was up 38% at the September 25 close of 201.97. Meanwhile the latest reported quarter is still the one that ended June 28. Nothing in our feeds explains the rally, and the hyperscaler and SpaceX talk is explicitly unconfirmed. Expectations have drifted up with no new evidence, while the evidence we do have on margins, costs and cash flow has kept moving the other way. I can't prove that's hope, but I can't find anything else in the data. It raises the bar for the print.

Neutral, you say a quarter position under-participates in an 11% gap up. It does. But your plan rebuilds only on evidence after the print, so after a good print you're buying back above 178 too. Under-participation is the price of any trim. The question is what the extra 25 points buys you. I'm not claiming an edge on direction. I'm saying the good case is a conjunction: gross margin near 53%, cost growth slowing from 22%, free cash flow recovering, and a credible guide. That's your own checklist. The bad case needs only one of those to disappoint badly. With a beta of 1.65, that asymmetry argues for less stock, not a split-the-difference half.

On your comparison trap, revenue down 3 to 4% year over year is the same rate as FQ2 and FQ3, so that's the existing trend. And on the derived numbers FQ4 ran about 9% above FQ3 last year, so a 9 to 10% sequential bump is just seasonality. I'd assume the Street models that, though I haven't seen consensus. If the headline says rebound and the stock pops, that's a gift to the quarter I still hold and a fine place to trim more. If the guide disappoints, the half position eats it.

I do like your idea of selling into 185 to 195. But walk your plan through the paths. On a rally you end at 25% like me, at a better price. On a break below 168.16 you end at 25% like me, at a worse price. The real disagreement is the sideways case, and October's closes ran 172.11 to 184.87, so sideways is the likeliest path. The question is whether you hold half on print day, and I say no.

Conservative, on the 30% stress, I'm with the neutral that you've merged gap risk and path risk. The 41% fall took two months, and the worst single-day drop in the series is 8.5%. So 18% is already more than twice the worst down day we've seen, and 30% is three and a half times it. The plan handles the grind with a rule and the gap with size. If a caller's budget is tight, the formula takes them below 25% on its own, and I'm happy to call 25% the ceiling.

On 168.16, I wouldn't make it a mechanical halving. The neutral's rough odds of a third to a coin flip over ten sessions sound right to me, and a rule that fires that often is a second trim, not a stop. But you're right that a vague review isn't enough. So pre-commit: a close below 168.16 forces a decision the next session, and the default is to hold a remainder that was already sized for a much bigger drop, unless news explains the break.

Two last things. Layoffs start in November, after the quarter closed, so the print can explain costs and give a plan but can't show savings. A "tell us" print gets decided on guidance, and I'd rather meet that with a quarter of a position. And if implied volatility into earnings is rich, as you both suspect, selling stock beats buying protection. A collar also gives away upside, which is exactly what the neutral objects to in my trim.

So here's what I'd tell the caller. Trim to a quarter of a standard allocation or less, size the remainder as loss budget divided by 0.18, and add nothing before the print. Treat 168.16 as a pre-committed decision point with hold as the default. Rebuild only on the neutral's evidence list, which is a set of suggestions and not data-derived thresholds. If you're already at a quarter or less, leave it alone. Being aggressive isn't holding the most. It's having the most flexibility when the price finally reprices.

FINAL TRANSACTION PROPOSAL: SELL (trim to about 25% of standard size or less, remainder sized to loss budget divided by 0.18, no new money before the print) Aggressive Analyst: We agree on direction, on no new money, and on a loss-budget cap. I'll say what I'm taking from each of you, then defend the one thing I'm keeping.

Conservative, you're right that "hold by default" isn't a rule, and I'll take your filter: two consecutive closes below 168.16, or one close below 165.58, halves the remainder. My 18% formula covers a gap but not a grind. A 30% slide on a position sized for 18% costs about 1.7 times the budget. Neutral, I know you'd leave a quarter alone, but whipsawing it is cheap. Halving 25 points and then watching a 4% bounce costs about half a point of a standard position, and that buys protection against the path the sizing can't see. I also agree to retire valuation, the technicals, the Fed and the rally story. "The price already contains the answer" can't be shown without consensus numbers. The case rests on the filing trend, the information we can't see, and a 1.65-beta stock going into a binary event.

Neutral, you're right on three things. Pairing realized with realized is the fairer comparison. The asymmetry I leaned on came from a stress number we chose, not from the observed distribution. Your checklist is a rebuild bar, not a bar for the stock to rise. And taxes are real. I can't price them, and they're the one legitimate reason to stay above a quarter. In that case hedge the excess instead of ignoring it.

You also said the loss-budget formula handles width, so going below half is a bet on a negative center. That's accurate, and I'll own it. Here is why I make that bet.

First, every verified number has pointed the same way for three quarters. The offsetting items are a target raise worth under 4% upside from 178.28, ETF flow that is noise against a $190B cap, and unconfirmed rumors. That doesn't prove negative skew. As a general tendency, not something computed from our data, margin trends tend to persist from one quarter to the next. If the Street already models that, persistence isn't a surprise, so I'm calling this a lean and not a finding. But when all the hard evidence points one way and the rest is rumor, the lean should be toward less stock.

Second, the starting points differ. The 11% April gap came from 132.73, after the stock had been beaten down to 122.94. Today it sits 45% above that low and 21% above the July close. Relief gaps are easier to get from a low base. That's an inference from three events, one of each sign, so I wouldn't lean on it hard.

Third, the sell-into-strength tranche fits poorly with a no-edge premise. If we can't call direction, a limit at 185 to 195 is worth nothing in expectation. It also costs about seven sessions of exposure on 25 points the plan already says to sell. The stock fell 5.8% on Sep 18 and 7.2% on Sep 28 with nothing in our feeds to explain either. It needs a 4 to 9% rally, which your own sideways path says is unlikely, so the fill is probably the Oct 30 deadline anyway. Selling now and selling at the deadline differ only by the variance in between.

Fourth, your step-down rule protects against a grind but not against the print itself. A gap through 168 and 165.58 never gives you two closes, so on the most dangerous path you hold half through the entire move and the rule never acts. On that path only size protects you.

On your trap point, I think you're right that the optics will be easy. Using derived numbers, if revenue is down 3 to 4% year over year, that's roughly $10.9B. Take gross margin near 53% and operating costs flat at FQ3's implied $3.65B. Operating income comes to about $2.1B, a margin near 19 to 20% against 16.3%. That's my rough arithmetic. It would look like a turn on seasonality alone, with no change in cost growth. The stock could pop on it, and a quarter position means I'm neither forced to chase it nor to capitulate on it. The real read is year-over-year cost growth and the guide. Waiting a session or two before rebuilding is the right discipline for that reason.

For the caller, anyone above a quarter of a standard allocation should go to a quarter now, or to loss budget divided by 0.18 if that's lower. Don't wait for a rally. Add nothing before the print. If taxes or a mandate block the sale, hedge the excess with a collar or put spread, though I haven't seen the options chain. If you're at a quarter or less, leave it alone. Halve the remainder on two closes below 168.16 or one close below 165.58. After the print, wait a session or two and rebuild only on evidence, using the neutral's checklist as suggestions, not data-derived thresholds.

If someone wants to argue me up from a quarter, the most I'd call defensible is half, sold now. I wouldn't accept three quarters held while waiting for a better fill, and I wouldn't accept full size.

FINAL TRANSACTION PROPOSAL: SELL (trim to about 25% of standard size or loss budget divided by 0.18 if lower, now; no new money before the print; halve the remainder on two consecutive closes below 168.16 or one close below 165.58; rebuild only on evidence after the print) Aggressive Analyst: Good, this is nearly settled, so I'll say what I'm giving up and what I'm keeping.

First, what I'm giving up. Staging is gone, and I'm glad. Neutral, you're right about the two arms of the step-down rule. A gap day that closes below 165.58 trips the one-close arm, so I was wrong to say a gap never triggers it. Your worry is also fair: a mechanical cut at the low of an earnings reaction is a bad outcome. I'll let the rule expire at the print. Its job is the grind between now and the report. Afterward we all want to wait a session or two, and the evidence list decides.

I'm retiring the conjunction argument too. My own arithmetic showed revenue down 3 to 4% with flat costs gives a margin near 19 to 20% on seasonality alone. The print can look better without anything improving underneath, so "good needs four hits, bad needs one miss" doesn't describe how it will read. And your reaction-versus-trend point is a good one. February sold off after a record revenue quarter, and April gapped up after a 26% drop in operating income. Both have inferred dates and there are only two of them, but they say the filing trend is a poor guide to the reaction. So I'm done calling the quarter a view. Conservative has it right: it's insurance against an event none of us can read.

Now what I'm keeping. Neutral, you say that if the marginal 25 points is worth about zero, holding it costs nothing in expectation and only adds variance. But "about zero" rests on the same two events you told us don't define a distribution. If that's fair, we don't know it's zero either. What we do know is the size of the stakes: plus 2.75 against minus 2.1 on realized moves, or 3.75 to 4.5 on the stress. We are arguing over roughly half a point to two points of a standard allocation. That is smaller than the error in most numbers we've used all week, so a person's own risk budget should settle it, not a claim about what the data shows.

On "insurance proves too much, so why not 10%," you're right that the logic needs a stopping point. Insurance isn't free, because every point sold costs participation if the print is good. You stop where more comfort isn't worth the lost upside. That is a judgment call, and I'd rather say so than pretend the data picks 25. The one thing I can add is that the hard evidence is one-sided. Three quarters of filings point one way, and nothing verified points the other way except a target raise worth about 3.8% upside and ETF flow that is noise against a $190B cap. That doesn't prove negative skew, and I'm not claiming it does. It only explains why, with no view, I pick the lower of two defensible numbers.

I also like what a quarter does after the print. Both the April run and the February slide lasted weeks. A clean read on guidance and cost growth, with most of your capital free to act, is a better place to decide from than the gap itself. Conservative made this point, and I agree with it.

On taxes, I agree, and I said earlier it's the one legitimate reason to stay above a quarter. For a taxable account with large embedded gains, selling and rebuying isn't free, and that's a real reason to sit at half. In that case half is the most I'd defend. Anything above half should be sold or hedged, not held out of inertia. For an IRA or an institution, the friction is near zero and I'd go to a quarter.

One practical note. Today's bar is incomplete, so don't build the trade around 178.28. Execute in a normal session in one step, not at a limit you're hoping to hit.

So here's what I'd tell the caller. If you hold more than a quarter of a standard allocation and have no tax friction, sell to a quarter now, or to loss budget divided by 0.18 if that's lower. If taxes bind, go to half at most, with the same loss-budget cap, and hedge anything above that. If you're at a quarter or less, leave it alone. Add nothing before the print. Between now and the report, halve the remainder on two consecutive closes below 168.16 or one close below 165.58, and let that rule lapse at the print. After the print, wait a session or two and rebuild only on evidence, using the neutral's checklist as suggestions, not data-derived thresholds.

The three of us now agree on direction, timing, sizing logic and the evidence we can't see. What's left is a half-point question that should be settled by your tax situation and your tolerance for an event we can't read. I'd rather meet that event with capital free to act.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, to about 25% of standard size or loss budget divided by 0.18 if lower; half is acceptable only where tax friction binds, with any excess sold or hedged; no new money before the print; halve the remainder on two consecutive closes below 168.16 or one close below 165.58, with that rule lapsing at the print; rebuild only on evidence after the print) Aggressive Analyst: Some housekeeping first, since all three of us agree on it. The step-down rule lapses when the company actually reports, not on Nov 4, and someone should check the investor relations calendar before anything leans on that date. Neutral is also right that the 200 SMA and the lower Bollinger band move with every bar, so write down 168.16 and 165.58 today. The 10-21 bar is incomplete, so nobody should execute against 178.28. Use a normal session.

Neutral, your July example is the best new argument, so I'll size it before answering. A holder who cut after that print and waited for evidence would have sat out a 38% run from 146.81 to 201.97. Run the same arithmetic the other way. The fall from the May 29 close of 248.74 to 146.81 was about 41%, with margins sliding throughout. Twenty-five points of a standard position is worth about 9.4 points of allocation on the run and about 10.2 on the fall. That doesn't favor half. It's the point Conservative has been making: the extra 25 points is a swing of similar size in both directions, and nothing in our data says which way it breaks. The starting points also differ. Your example sells at a trough after a 41% drop, and ours trims after a 21% bounce.

But "cuts fast, adds slowly" is a real flaw, and I'd fix it in the rebuild rather than by holding more now. Pre-commit a first rebuild step a session or two after the print if management gives a credible cost explanation and the guide isn't a cut. Don't wait for free cash flow to prove itself over another quarter. Then being underweight lasts days, not months. That's my suggestion, not a data-derived rule.

On burden of proof, I'll drop my own framing and not adopt Conservative's. Neither direction is the riskless default. Selling carries certain costs and the risk of being underinvested, and holding carries the gap. I accept your function: the loss cap sets the ceiling, tax friction sets the floor, and what's left is a preference.

I'd push back on "the first fifty points are evidence and the last twenty-five are preference." Our evidence is the filing trend, the things we can't see, a 1.65 beta and a binary event. None of it picks 50 over 25 or 75 over 50. All three of us agreeing on the first 50 doesn't make that number derived. The whole size is a judgment about how much a bad gap should be allowed to hurt, and I'd rather say so than hide it in a default. For a caller who tells us nothing, I'd still say a quarter, and I'd label it a preference.

Your no-trade band is fair. Someone at 35 or 40 percent shouldn't be told to sell 10 to 15 points on my say-so. The spread on a $190B stock is trivial, so the real cost is tax and re-entry, which means friction should define the band. If selling is free, a quarter is a reasonable choice and I lean that way. If selling triggers a real tax bill, leave anything under half alone, with no buying before the print.

So the answer is a function. Never hold more than loss budget divided by 0.18. Frictionless callers go to about a quarter and taxable callers with embedded gains stay at or below half. Anything above the target that can't be sold gets hedged. A collar sells rich implied volatility, but I haven't seen the options chain.

The bold part of this plan isn't the sale. It's reaching the print with capital free for a reaction nobody can read from here, and with a rebuild rule that doesn't leave you stuck underweight if the print is fine.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, in a normal session; target about 25% of standard size absent tax friction, up to 50% where friction binds, never above loss budget divided by 0.18; no trade needed inside that band if selling is taxable; hedge any excess that can't be sold; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58, using fixed levels, lapsing when the company actually reports; after the print wait a session or two, then rebuild in steps on evidence, starting with a first step if the cost explanation is credible and the guide isn't a cut)

Conservative Analyst¶

Conservative Analyst: I agree with the direction of the trade: cut exposure before the Oct 29 FOMC and the early-November print. But I don't agree with all of the reasoning behind it, and I think the sizing is less conservative than it looks.

The aggressive analyst is right about the core of it. Operating margin went 27.5, 21.8, 16.3. Free cash flow went 4.4, 1.9, 0.5. Operating income was down 5, 26, then 41 percent, and I checked those against the filings data. The things that would show a turn, like guidance and an explanation for 22% cost growth, don't arrive until the print. That is the case for trimming.

Some of the supporting arguments are softer than presented. The 25x and 31x EV/EBIT figures use an enterprise value built on $4.5B of cash, with no marketable securities in the data, so EV is probably overstated. Trailing P/E is 20.6x and forward is 17.5x. The cleaner valuation point is that FQ3 EPS of $1.87 annualizes to about $7.48, which is roughly 24x, and that is with below-the-line items helping, since net income exceeded operating income. The 17.5x forward multiple only works if EPS jumps to $10.19, and three quarters of data don't support that.

I wouldn't lean on the Fed argument. The hike tail has already collapsed from about a third to 14% in a week, and our rates, yield and VIX feeds all failed, so we're reading the regime from prediction markets alone. The $10.0B of "shareholder returns" is total financing outflow, and the tool doesn't split out debt repayment. The direction still holds, since cash fell from $7.2B to $4.5B. And the 10 to 11% event moves are really 8.5% in February and 11% in April, with the link to earnings dates inferred rather than confirmed.

Those corrections make me more cautious, not less. The stock dropped 5.8% on 54M shares on Sep 18 and 7.2% in one day on Sep 28, and nothing in our data explains either. The risk isn't confined to the two scheduled events.

That brings me to sizing. Sizing the remainder off an 18% fall treats the July close as the bad case, but the stock went from 248.74 to 146.81, about 41%, in two months. The 52-week low is 32% below today's price. If I size to a 30% stress instead of 18%, the position is 40% smaller. I'd treat 25% of standard size as a ceiling, not a target, and let the stress rule decide.

I'd also change two things in the plan. "Dry powder at better prices" is a reflex I don't trust. A lower price isn't a reason to buy. A stabilizing margin and a credible cost explanation are. And a review trigger at 168 isn't enough. Gaps skip stops, which is an argument for deciding the response in advance. If it closes below the 200 SMA at 168.16, act the next session by cutting the remainder in half or exiting.

I expect the neutral analyst to say RSI is 50, the z-scores are flat and the averages are stacked bullishly, so wait for the print. RSI and z-score tell you price isn't stretched. They don't tell you what a print does, so they're descriptions, not forecasts. Holding full size through a binary event isn't neutral, it's a position. The weekly SuperTrend, which the technical report weights highest, is down at 223.47. The whipsaw explanation for the moving averages is an interpretation rather than proof, so I'd call the averages a wash and not lean on them either way.

The neutral analyst may also cite the 5.4% FCF yield and the 2.1% dividend. TTM free cash flow of $10.24B is flattered by a strong FQ1 and the implied FQ4 FY25, while the latest quarter produced $0.5B. The dividend isn't in danger near term, since annual FCF covers it about 2.3 to 2.6 times. But an 18% decline is about $32 a share, and the dividend is about $3.70 a year, so one bad gap erases more than eight years of dividends. The Susquehanna target of $185 is under 4% upside from 178.28, less than one day's average range of 6.90. The $121M of ETF buying is about 0.06% of market cap.

Finally, we're missing segment data, guidance, any explanation of the cost growth and the tax items, and the macro feed, and today's bar is incomplete. When you can't see why the numbers are moving, the conservative answer is smaller size, not waiting at full size. If a trim isn't practical because of taxes or a mandate, a put spread or collar is worth looking at. I don't have the options chain, so I can't price it, and protection ahead of earnings is usually expensive.

FINAL TRANSACTION PROPOSAL: SELL (trim to at most about 25% of standard size, sized to a 25 to 30% stress, no new money before the print) Conservative Analyst: We've narrowed this a lot. All three of us say sell, add nothing before the print, and size off a loss budget. The open questions are quarter versus half on print day, and what to do at 168.16. I'll start with what I'm giving up.

The 30% stress was too much to hang on one print. The worst single-day drop in the series is 8.5%, and I merged gap risk with path risk. I'll use 18% as the working gap number, though I'd call it a floor. In February the stock fell 8.5% in a day, then kept sliding to the 122.94 low in April. That's about 16% from the pre-drop level, so 18% is a gap plus some follow-through. I'll also drop the dividend comparison. And you're right that the valuation argument is the margin question again. I'd retire it as independent evidence.

The neutral is also right about my halving rule. By my rough arithmetic, with closes moving a couple of percent a day and 168.16 about 5.7% away, the chance of at least one close below it in ten sessions is somewhere between a third and a coin flip. A trigger that fires that often shouldn't cut a quarter position in half. I'd change it to two consecutive closes below 168.16, or one close below the lower Bollinger band at 165.58. Either one halves the remainder. That's still a pre-committed action, just with less noise.

I still don't accept the half position, for three reasons. First, the neutral's plan mostly collapses to a quarter anyway. If the stock rallies, tranche two is sold. If it breaks, the rule takes you to 25%. Only the sideways path keeps half, and October's closes say sideways is the likeliest. So half is really double the exposure in the scenario where you learn nothing before the print. Tranche two also needs a 4 to 9% rally within about ten sessions, and the earnings date is unverified. If the report comes earlier than early November, that tranche never gets sold. I'd make the decision now, before the calendar makes it for me.

Second, the neutral said missing data cuts both ways and that not knowing argues for smaller size. That is my argument. We have no consensus, no segment data, no guidance, no explanation for 22% cost growth, no macro feed and no options chain. In that situation conviction shouldn't set the size, the width of the outcome range should. Take the extra 25 points. An 11% gap up adds about 2.75% of a standard position. A 15 to 18% gap down costs 3.75 to 4.5%. With the only hard evidence trending the wrong way, I don't see that being paid for.

Third, "at or below half, don't sell down" leaves someone sitting at 50% with exactly the exposure we're worried about. I'd take anyone above a quarter down to a quarter.

I agree the print's comparisons will be strange. FQ4 last year was a derived loss of about $3.1B, so year-over-year EPS will look dramatic, and sequential revenue will probably be up 9 to 10% on seasonality. That makes the first reaction noisier in both directions, which is another reason to arrive smaller and to wait a session or two before rebuilding.

To the aggressive analyst, I agree on the quarter, but some of your arguments are soft. A rule whose default is "hold" isn't a rule. Your loss budget formula tells you how much you can lose without damage. It doesn't tell you that you should still own the stock. I'd pre-commit to the action.

I'd also be careful with "expectations drifted up with no evidence." I can't find an explanation for the rally in our feeds either, but we have no consensus or segment data, and the hyperscaler talk is unconfirmed rather than disproven. That's a reason for size, not a diagnosis of hope. And "the price already contains an answer" can't be shown without knowing what the Street expects.

So I'd rest the case on three things: the filing trend, the information we can't see, and a 1.65-beta stock heading into a binary event. I'd drop valuation, technicals, the Fed and the rally narrative, since they're easy to knock down.

For the caller, anyone above a quarter of a standard position should go to a quarter, or to the loss-budget number if that's lower, now, without waiting for a rally. Add no new money. If you're already at a quarter or less, leave it alone. Use the two-closes or 165.58 rule to halve what's left. After the print, rebuild only on evidence, using the neutral's checklist as suggestions, not data-derived thresholds. If taxes or a mandate block selling, a collar or put spread is the fallback, even though it gives up upside and implied volatility is probably rich. I haven't seen the chain.

FINAL TRANSACTION PROPOSAL: SELL (trim to at most about 25% of standard size, or the loss-budget number at an 18% stress if lower, now and before the earnings date is confirmed; no new money before the print; halve the remainder on two consecutive closes below 168.16 or one close below 165.58; rebuild only on evidence after the print) Conservative Analyst: We're down to one real disagreement: carry a quarter or half into the print, and whether to stage the sale. The aggressive analyst and I are close, so most of this is for the neutral, but I have something for the aggressive too.

Neutral, start with your own plan's mechanics. Staging in two tranches means that on the choppy path, which we all agree is the most likely, you sit at 75% for up to seven sessions, from Oct 22 through the Oct 30 close. That breaks the loss-budget cap your plan sets for the remainder. It's also the window where the stock dropped 5.8% and then 7.2% in September with nothing in our feeds to explain either. The only reason to wait is a better fill, and a limit at 185 to 195 has no edge unless someone can call direction, which none of us claims. Staging buys variance, not price. If half is the target, sell to half now.

On pairing realized with realized, I accept the correction. The observed event moves are closer to symmetric than my 18% stress made them look. But look at what that concedes. Plus 2.75 against minus 2.1 is roughly zero expected value with an unknown sign. The extra 25 points isn't earning anything we can show. I don't need to prove negative skew to prefer less variance, only that the data doesn't show those points paying. You said the loss-budget formula handles width, and I agree, but it tells you the most you may hold, not how much you should. It's a ceiling, not a target.

One more point on the April run and the February slide. Both trends lasted weeks, five weeks up and two months down, so most of what followed each event could be acted on afterward. What you can't react to is the gap. Rebuilding on evidence after the print therefore gives up less than it sounds like, mostly the gap itself, and that gap is the only thing size decides. I'll own that a quarter position under-participates if the print is good. That is the price of insurance I can't price any better.

Taxes and re-entry costs are real, and I concede nobody priced them. But the caller's basis isn't in the data, and I wouldn't set the default around a cost that hits a taxable account with big gains and misses an IRA or an institution. Someone who stays above a quarter for tax reasons should hedge the excess with a collar or put spread, not hold it unhedged because half feels like a compromise. I haven't seen the options chain, so I can't say what that costs.

Your 87% run from April 24 to May 29, with margins already sliding, is your best humility argument. I read it the other way. A stock that can rise 87% in five weeks and fall 41% in two months, on information I can't see, is one I want to hold small. That's an argument for size, not for half.

Aggressive, I agree with selling now instead of waiting for a fill, and with half as the most you'd defend. But you've weakened your own case. You said you make a bet on a negative center, and then you defended it with persistence of margin trends, which you admitted isn't computed from our data, and with relief gaps being easier from a low base, which rests on three events. The neutral wins that argument, because nothing here supports a directional bet. Your own arithmetic also shows that revenue down 3 to 4% with costs flat gives about a 19 to 20% margin, which looks like a turn on seasonality alone. A pop is therefore quite plausible, and I won't claim the downside gap is more likely than the upside one. My case is that I can't tell which is coming, I have no consensus, guidance, segment data or options chain, and I shouldn't carry more than I can afford to lose either way. Defend the quarter as insurance against an unreadable event, not as a view.

On the 168.16 rule, the whipsaw cost at a quarter is about half a point. That's cheap protection against a grind, so I'd keep it. It's the first rule I'd drop if a caller finds it too fiddly. You're right that it can't help on a gap, so size has to do that work.

For the caller: if you hold more than a quarter of a standard allocation, sell down to a quarter now, or to loss budget divided by 0.18 if that's lower, in one step. Add nothing before the print. If you're at a quarter or less, leave it alone. If taxes or a mandate block the sale, hedge the excess. Halve the remainder on two consecutive closes below 168.16 or one below 165.58. After the print, wait a session or two and rebuild only on evidence, using the neutral's checklist as suggestions rather than data-derived thresholds.

FINAL TRANSACTION PROPOSAL: SELL (trim in one step, now, to at most about 25% of standard size or loss budget divided by 0.18 if lower; no staged tranches and no waiting for a better fill; no new money before the print; hedge any excess held for tax or mandate reasons; halve the remainder on two consecutive closes below 168.16 or one close below 165.58; rebuild only on evidence after the print) Conservative Analyst: We're down to a disagreement small enough to name exactly. All three of us sell in one step now, add nothing before the print, and rebuild only on evidence afterward. I'll also accept letting the step-down rule lapse at the report. The neutral is right that a mechanical cut at the low of a gap day is the worst time to act. One condition: the report date is still unverified, so the rule should lapse when the company actually reports, not on a date we guessed. Check the investor relations calendar before leaning on Nov 4.

What's left is the default for a caller we know nothing about: a quarter or half.

Neutral, your reaction-versus-trend point is the best new argument this round, but I think it uses only half the record. The technical report shows big gap and volume clusters in late October 2025, early February, late April and late July. February and April ran against the reported trend. Late July came after the weakest print yet, with operating income down 41%, and the stock was sliding toward 146.81 by month end. I don't have a clean one-day number for that one, and the link to earnings dates is inferred, so I wouldn't lean on it. Still, on its face it's a print where reaction and trend agreed. October 2025 I can't read at all. So the record is two against, one with and one blank. That doesn't show the trend is a bad guide. It shows we can't tell, and "can't tell" argues for smaller size. You said a quarter "says the filing trend should dominate." It doesn't. A quarter is the same agnostic position as half, with less riding on an event that has moved the stock 8 to 11% in either direction.

You also said that if the extra 25 points is worth about zero in expectation, holding it costs nothing in expectation. I agree, and that's my point. It costs variance, and nothing pays for it. Then you said taxes break the tie. I agree again, and I've already conceded half to anyone with real friction, with the excess hedged. So we share a decision rule: no friction means a quarter, friction means half. The only question is which way to lean when the caller hasn't told us. I'd put the burden of proof on the reason to hold more risk, not on the reason to hold less.

On the loss budget, I accept that a loss below the cap is affordable by construction. But the cap is a ceiling on what you may hold, not an argument for holding it. It's also calibrated to 18%, which I called a floor. The aggressive's arithmetic shows a 30% slide on a cap-sized position costs about 1.7 times the budget. If the caller's budget is generous enough that the cap doesn't bind at half, half is inside the limit. That makes it permissible, not better.

On "insurance proves too much, so why not 10%," it proves as much as the premium allows. The premium is lost participation, about 0.11 of a point for every point sold if we get an 11% pop. At some point selling more becomes a view that the stock is a sale, and I don't hold that view. Leverage is moderate, the current ratio is about 2, and a quarter keeps real exposure. A quarter is also where an 18% gap costs about 4.5 points of a standard allocation, which a caller can absorb without being forced into a decision. That's a judgment, and I'll say so, but half is a judgment too.

Aggressive, I'm on your side of the number. I'd only add that "the lower of two defensible numbers" sounds like a rule when it's a preference, and you mostly said as much. I agree with executing in a normal session in one step, since today's bar is incomplete and nobody should anchor on 178.28.

One last thing about the print. The first read will mislead in both directions. The year-ago FQ4 comparison carries a derived loss of about $3.1B, so EPS growth will look dramatic. Seasonality alone can lift margin toward 19 to 20%, by the aggressive's arithmetic. The lines that matter are year-over-year operating cost growth against 22%, gross margin against 53%, free cash flow against the latest $0.5B, and the guide. Wait a session or two, then rebuild in steps rather than on the headline.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, in a normal session, to about 25% of standard size or loss budget divided by 0.18 if lower; half is acceptable only where tax friction or a mandate binds, with anything above that hedged; no new money before the print; halve the remainder on two consecutive closes below 168.16 or one close below 165.58, with that rule lapsing when the company actually reports; wait a session or two after the print and rebuild in steps, only on evidence) Conservative Analyst: We've agreed on enough that I'll spend this on the two places where I still have something to add: the July example and the rebuild.

On housekeeping, I agree with everything. Write down 168.16 and 165.58 as fixed numbers today, check the investor relations calendar, and don't execute against the incomplete 178.28 bar. I'd tighten the lapse rule, though. The neutral is right that a mechanical cut at the low of a reaction is the worst outcome. But "lapses when the company reports" leaves a gap. If a close below 165.58 lands on the last session before the release, the order executes at the open of the reaction session. So I'd drop any step-down signal that would execute into the reaction session. I believe they usually report after the close, but that's from memory, not our data.

Neutral, on the July example, I'll take the lesson and argue with the details. The aggressive already showed that 25 points of position swings about 9.4 points on the run and 10.2 on the fall, and that your example sells at a trough while ours trims after a 21% bounce. I'd add that the run wasn't news-free just because no filing arrived. The technical report shows a gap up on 26.1M shares on Sept 8 that nothing in our feeds explains. Then came a 5.8% drop on 54.5M shares on Sept 18 and a 7.2% drop on Sept 28, also unexplained. So something we can't see moved this stock hard in both directions inside three weeks. That doesn't argue for holding more. It says the hidden channel is large and two-sided, which is the case for sizing to the gap instead of to a view.

You're right about the real flaw, though. Cutting fast and adding slowly can leave you stuck underweight, and that cost is real. I'd fix it in the rebuild, as the aggressive suggested, but make it specific. A first step a session or two after the print is fine. But we have no consensus, so "the guide isn't a cut" is a low bar, since a guide can avoid a cut and still miss what's priced. I'd keep that first step small, maybe a third of the way back to target. That's my suggestion, not a derived number. It ends the stuck-underweight problem without betting that the print was good. Bigger steps need the checklist: cost growth explained against the 22%, gross margin near 53%, and cash flow moving off $0.5B. If the explanation isn't there, stay at the quarter or go lower. Price alone shouldn't trigger a step. The year-ago loss of about $3.1B will make EPS growth look dramatic on the first read, and that isn't evidence.

I'd also say this is where the real decision sits. The pre-print gap between a quarter and a half is worth roughly two to four and a half points of a standard allocation, depending on which move you pair. The rebuild rule shapes the next several months, and this stock has had 40% legs in both directions in the last year.

On the no-trade band, I accept it. Friction defines it, and someone at 35 or 40% with a large embedded gain shouldn't sell on our say-so. One condition: the band can't override the loss cap. Taxes change what selling costs, not what the position can lose, so if the cap says less than they hold, they should hedge the excess.

On the default, I'm dropping the burden-of-proof line. You're both right that selling carries its own risk, and I can't show a quarter beats half. For a caller who tells us nothing, I'd still say a quarter, but as a preference, the same way the aggressive does. The three of us now give the same function: the loss cap first, tax friction second, preference for lower variance third. We differ only on which number to name when forced, and neither number is derived. I'd tell the caller to answer two questions, their tax situation and their risk budget, and then read the answer off that function.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, in a normal session; target about 25% of standard size or loss budget divided by 0.18 if lower; up to 50% where tax friction or a mandate binds, with anything above that sold or hedged; no trade needed between a quarter and a half if selling is taxable, but never above the loss cap; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58, using fixed levels, dropping any signal that would execute into the reaction session; after the print wait a session or two, then take a small first rebuild step if the cost explanation is credible, and add further steps only on evidence)

Neutral Analyst¶

Neutral Analyst: I agree with both of you on direction, so I'll start there and then argue about size. Holding full size into a print after three straight quarters of margin slide, with no explanation for the cost growth, is a position, not a default. But cutting to a quarter treats a moderate-conviction view as a high-conviction one, and the data doesn't earn that.

To the aggressive analyst: the valuation argument is really a margin argument counted twice. The 31x figure annualizes FQ3, which is a seasonal low quarter. Last year it ran about 6% below the average quarter, so that math overstates the multiple. More importantly, EV/EBIT is high because EBIT is depressed. Using your enterprise value on about $44B of trailing revenue, a 16% margin gives roughly 28x, a 20% margin about 23x, and a 25% margin about 18x. The stock is expensive only if margins stay put, and that is exactly the question the print answers. It isn't independent evidence.

I'd also push back on the "win both ways" framing. If QCOM gaps up 11%, a quarter-size position under-participates, and using the cash means buying back above where you sold. If it gaps down, the drop most likely confirms the bear case, so "better prices" isn't automatically an entry. The Fed argument is also thin. The hike tail fell from about a third to 14% in a week, and no cuts in 2026 is already 97% priced. The print is the event, not Oct 29.

To the conservative analyst: you were right to scrub the aggressive numbers, but some of yours need scrubbing too. Cash "falling from $7.2B to $4.5B" starts at the December peak after a record quarter. Against September it's down about $1.0B, and the financing numbers don't reconcile with the cash change anyway. Annualizing FQ3 EPS to $7.48 uses the same seasonal trough. Sizing to a 30% stress is the bigger problem. The 41% decline took two months, not one print, and the biggest single-day moves in the data are 11%, 8.5%, 7.2% and 5.8%. Gap risk, which sizing handles, is probably 15 to 18% in a bad case. Path risk, which a rule handles, is separate, and you've merged them. I'd also drop the dividend comparison. Eight years of dividends is a vivid number, but the yield doesn't matter over a two-week window for either side.

Your 168.16 rule worries me too. That level is about 5.7% away, roughly 1.5 daily ranges, and there are about ten sessions before the print. My rough guess, not computed from the data, is a one-in-three to coin-flip chance of at least one close below it. Starting at 25% and halving to 12.5% could leave almost nothing right before the report, and that's selling into noise. Also, missing data cuts both ways. If we can't see why costs rose 22%, we can't say they persist. Capex roughly doubled and the layoffs haven't started, so some of that may be investment or one-offs. Not knowing argues for smaller size, not maximum conviction.

One trap for both of you: the print's comparisons are distorted. The derived FQ4 FY25 quarter shows about $11.3B of revenue and a roughly $3.1B loss, so GAAP EPS will look like a huge year-over-year improvement. If revenue lands 3 to 4% down year over year, that's still a sequential bump of 9 to 10%, which headlines may call a rebound. "Nothing shows a turn" doesn't mean the print will be bad, only that we can't tell. The reaction will hinge on guidance and gross margin against expectations we haven't seen.

The technicals are a wash. The weekly SuperTrend at 223 is a regime filter about 25% away, so it says don't add, but it doesn't time a two-week window. The average stack is a whipsaw artifact, and RSI at 50 only describes the present.

So here's my adjustment. Trim to about half of a standard allocation in two tranches, and don't anchor on 178.28, since today's bar is incomplete. If the stock rallies toward 185 to 195, which is the upper Bollinger band and the daily flip level, sell the second tranche into that strength rather than into a dip. Size the remainder as the smaller of 50% or loss budget divided by 0.18. The plan lists 168 as a stop loss and also says it isn't a hard stop. I'd drop the stop label and use a close-based rule: a close below 168.16 takes you to about 25%.

After the print, rebuild only on evidence, not price. That means gross margin holding near 53%, cost growth decelerating from 22%, free cash flow moving back toward the roughly $1.9B of FQ2, and a credible guide. Cut toward 25% or less if margins slip further with no cost explanation. These markers are my suggestions, not data-derived thresholds.

If you're already at or below half, don't sell down to a number, and don't initiate full size before the print. A quarter-size starter is fine if a mandate forces it. If taxes make trimming impractical, price a collar, though implied volatility into earnings is likely rich and I don't have the chain.

FINAL TRANSACTION PROPOSAL: SELL (trim to about 50% of standard size in two steps, step down to about 25% on a close below 168.16, no new money before the print, rebuild only on evidence after it) Neutral Analyst: We're closer than the back-and-forth sounds. All three of us say sell, add nothing before the print, and size off a loss budget. Part of what's left comes from how you both read my plan, and part is a real hole you found.

First, the misreading. You both walked my plan through three paths and said that on a rally I end up at a quarter, just like you, at a better price. I wasn't clear. The two tranches are how you get from full size down to half. You sell the first now and the second into strength toward 185 to 195. A rally gets you to half at a better price, and only a break gets you to a quarter. So we differ in the rally and sideways paths, not just sideways.

Now the hole. As I wrote it, if the stock chops around, the second tranche never sells and you walk into the print at 75%, which is worse than either of you described. Conservative, you're right about that and about the unverified date. So I'm adding a deadline. The second tranche sells on strength, or at the Oct 30 close at the latest, or the session before the report if the date turns out to be earlier.

On 168.16, you're each half right. Conservative is right that a rule whose default is "hold" isn't a rule. Aggressive is right that a single close below 168.16 fires too often to justify a mechanical cut. We guessed a third to a coin flip over ten sessions. So I'll take Conservative's filter of two closes below 168.16 or one below 165.58, and use it to take a half position down to a quarter. I wouldn't halve a quarter again. At that size the sizing has already done the work, and you'd be trading noise.

Conservative, you argue the extra 25 points isn't paid for, because an 11% gap up adds 2.75% of a standard position and a 15 to 18% gap down costs 3.75 to 4.5%. But the 11% is something the stock has actually done, while the 18% is a stress we chose, more than twice the worst down day in the series. Pair realized with realized, 11% up in April and 8.5% down in February, and the same 25 points is plus 2.75 against minus 2.1. The asymmetry came from the stress number, not the distribution. The February follow-through you cited took two months to reach the April low. That's path, which is what the rule is for.

You also said width of the outcome range should set size, not conviction. I agree, and the loss-budget formula is what handles width. If the formula says someone can hold half, going to a quarter is no longer about width. It's a bet that the skew is negative, and we've all said we can't see consensus, guidance or what's priced. Missing data is a reason to cap size, but it isn't evidence of negative skew.

Aggressive, the same problem runs the other way. The four-part conjunction is my rebuild checklist, which is the bar for adding capital, not the bar for the stock to rise. A stock can pop on an in-line margin and a better guide, just as it can drop on one weak line. The reaction depends on the surprise versus expectations, and none of us has seen those.

The rally narrative also depends on the anchor. The stock is up 21% from July 31, but it's down about 12% from the Sept 25 close and 28% from May. The last four weeks went the other way, so nothing says expectations have been climbing into this print. From the April 24 gap to the May 29 high, the stock went from about 133 to 249, up roughly 87%, with margins already sliding. I'm not saying fundamentals don't matter. I'm saying price and the margin trend have disagreed for long stretches, so a 75% cut claims more confidence than we've earned. I'd also keep valuation retired. A 22.5x multiple on seasonally adjusted GAAP EPS, set against a 17.5x forward that's probably non-GAAP, compares two different bases.

So the filing trend is real and it's our best evidence. It justifies cutting meaningfully, which is why I'm at half and not holding. But the data doesn't choose between 25 and 50. If the caller has a tight budget or more conviction than I do, a quarter is defensible. What I object to is calling it what the evidence requires. Neither of you has priced tax and re-entry costs either. Selling three quarters of a position that may carry big gains, to buy it back after the print, isn't free, and we don't know the basis.

For the caller, if you're above half, sell down to about half in two steps. Sell the first tranche now, and the second into 185 to 195 or by the Oct 30 close. Size the remainder as the smaller of 50% or loss budget divided by 0.18, and add nothing before the print. If you're already at half or lower, leave it alone and don't buy back before the print. Step down to a quarter on two closes below 168.16 or one below 165.58. After the print, wait a session or two and rebuild only on evidence, using the checklist as suggestions rather than data-derived thresholds. If taxes block selling, hedging the portion above half is the fallback. A collar also sells rich volatility, so it may cost less than an outright put. I haven't seen the options chain, so I can't price it.

FINAL TRANSACTION PROPOSAL: SELL (trim to about 50% of standard size in two tranches, the second on strength toward 185 to 195 or by the Oct 30 close at the latest; remainder capped at loss budget divided by 0.18; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58; rebuild only on evidence after the print) Neutral Analyst: Good, this is down to something answerable. First I'll give up the parts of my plan you've correctly taken apart.

The staging goes. Conservative, you're right that on the choppy path I'd sit at 75% for up to seven sessions, which breaks the cap I said should bind the remainder. Aggressive, you're right that a limit at 185 to 195 only has value if someone can call direction, and none of us claims to. Selling at the deadline instead of now differs only by variance on 25 points, and it ties the plan to a report date nobody has verified. So the plan is one step, now, to half or to the loss-budget number, whichever is lower. The Oct 30 deadline goes with it.

Aggressive, one fix on your fourth point. You said a gap through 168 and 165.58 never produces two closes, so the rule never acts. But the rule has two arms, and a gap day that closes below 165.58 trips the one-close arm on its own. It does act, just after the gap. That exposes my real worry, which is a mechanical cut at the low of an earnings reaction. I'd let the step-down rule expire at the print. Its job is the grind between now and the report. After that, the evidence list decides, and we all want to wait a session or two anyway. At a quarter I won't fight you on the rule, since it costs about half a point. At half it does real work.

Now the actual disagreement. Conservative, your best version is that the quarter is insurance, not a view, and that the extra 25 points shows plus 2.75 against minus 2.1, so it isn't earning anything we can show. I have two problems with that. First, those are two data points, and I leaned on the same two when I paired them, so I'm not claiming they define a distribution. I'm not asserting positive skew, only that nobody has shown negative skew. Second, if the marginal 25 points is worth about zero in expectation, holding it costs nothing in expectation either, and all it adds is variance. You said you shouldn't carry more than you can afford to lose. That is exactly what the loss-budget cap does. Below the cap the loss is, by construction, one you can afford. Going under it is a preference for lower variance, which is legitimate but isn't something the data found. And the insurance logic proves too much. If missing guidance, consensus and an options chain justify a quarter, they would justify 10%.

There's also something neither of you used. On the two prints where we can see the reaction, it ran opposite to the reported trend. The 8.5% drop in February followed a record revenue quarter with operating income down only 5%. The 11% gap in April followed a quarter where operating income fell 26% and margin fell more than six points year over year. Both caveats apply: the link to earnings dates is inferred, and it's two events. Still, our best evidence on the business hasn't been a good guide to the reaction, which turns on guidance and expectations we can't see. A quarter position says the filing trend should dominate. Half stays agnostic about which way the reaction function cuts.

Aggressive, your own arithmetic cuts against your conjunction argument. You showed that with revenue down 3 to 4% and costs flat sequentially, margin lands near 19 to 20% against 16.3%, with nothing improving underneath. If part of the good case arrives nearly free from seasonality, then "good needs four hits, bad needs one miss" isn't a fair description of how the print will read. The Street models seasonality too, so I'm not predicting a pop. But the asymmetry is smaller than you made it sound.

On taxes, Conservative, I agree basis isn't in the data and shouldn't set the default. But it does break the tie. If the marginal 25 points is worth roughly zero, then the certain costs of selling it and rebuying it decide the question, and those only run one way. For an IRA or an institution those costs are near zero, so a quarter is fine. For a taxable account with large gains, half is the better trade.

So the guidance is this. If you hold more than half of a standard allocation, sell to half now, or to loss budget divided by 0.18 if that's lower. If you're at half or below, leave it alone and don't buy before the print. If you have no tax friction and would rather carry less into an event you can't read, a quarter is a defensible personal choice, but it isn't what the evidence requires. If you can't sell, hedge the portion above half with a collar or put spread, though I haven't seen the chain. Add nothing before the print. Between now and the report, step down to a quarter on two closes below 168.16 or one below 165.58. After the print, wait a session or two and rebuild only on evidence, using the checklist as suggestions rather than data-derived thresholds.

FINAL TRANSACTION PROPOSAL: SELL (trim in one step, now, to about 50% of standard size or loss budget divided by 0.18 if lower; no staged tranches; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58, with that rule expiring at the print; quarter size is a defensible personal choice absent tax friction; hedge any excess held for tax or mandate reasons; rebuild only on evidence after the print) Neutral Analyst: We're down to a default for a caller we know nothing about, so I'll concede what's right, keep the one thing I think is still open, and make the guidance something you can apply without guessing.

Conservative, you're right that the step-down rule should lapse when the company actually reports, not on a date we inferred from a thin Polymarket contract. Checking the investor relations calendar costs nothing. I'd add one practical point: the 165.58 band moves with every new bar, and today's bar is provisional, so write down 168.16 and 165.58 as fixed numbers now. Otherwise the trigger drifts under you. I also accept your count of the record: two prints ran against the trend, one agreed with it, one is unreadable. I'll stop calling that evidence about the reaction function. It shows we can't tell, which is all I needed it to show.

I do still disagree with putting the burden of proof on the reason to hold more risk. Selling isn't the riskless default. It has certain costs, and it has a risk of its own, which is being under-invested when the market doesn't wait for evidence. Look at the one clean example in the data. After the 146.81 close on July 31, the stock rose about 38% to 201.97 by September 25, and as far as our feeds show, no new filing improved the margin story in that time. If you'd sold down after that print and rebuilt only on evidence, you'd have sat at your reduced size through most of that run. So "the gap is the only thing size decides" isn't quite right. The post-print rule is also a size decision. Ours cuts fast on bad news and adds slowly on good news. Starting lower on top of that compounds the underweight. The caveats are real: the print date is inferred, and no one would have bought at that low. But it's the same kind of evidence we've leaned on all week, and it cuts against the quarter as a costless default.

Aggressive, I agree that a person's own risk budget should settle a half-point question. That is why I'd write the answer as a function, not a number. The loss cap comes first, since it's the only part of this the data supports. Tax friction comes second. Preference for lower variance comes third, and it's legitimate as long as you choose it knowingly. For many callers the cap will already push them to a quarter or below, and for those the debate doesn't exist.

There's also a hole in the consensus line that "at a quarter or less, leave it alone." Someone sitting at 35 or 40 percent would be asked to sell 10 to 15 points to satisfy a rule, with certain spread and tax costs and an expected benefit we've all agreed is near zero. I'd use a no-trade band. Below half, friction decides. A taxable holder with embedded gains leaves it. An IRA or institution with no friction can go to a quarter without any argument from me.

If you forced me to give one number to a caller who tells me nothing, I'd still say half. The first fifty points of selling, from a full position, are what the filing trend and the event calendar support, and all three of us agree on them. The last twenty-five is a preference. I'd rather the caller pick it than have us hide it inside the default.

For the caller, then. If you're above half of a standard allocation, sell to half now, in one step, in a normal session, or to loss budget divided by 0.18 if that's lower. If you're between a quarter and a half, leave it alone if selling carries tax cost, and go to a quarter if it doesn't and you'd rather carry less into an event none of us can read. Add nothing before the print. Between now and the report, step down to a quarter on two consecutive closes below 168.16 or one close below 165.58, using the fixed levels, and let that rule lapse when the company actually reports. Hedge anything above your target that you can't sell. After the print, wait a session or two and rebuild in steps, only on evidence, using the checklist as suggestions rather than thresholds.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, in a normal session, to about 50% of standard size or loss budget divided by 0.18 if lower; about 25% is a fully acceptable choice absent tax friction; no trade needed if already within a quarter to a half and selling carries tax cost; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58, using fixed levels, lapsing when the company actually reports; hedge any excess that can't be sold; wait a session or two after the print and rebuild in steps only on evidence) Neutral Analyst: We're close enough that I'd rather tidy up than relitigate, so here is what I'm taking and where I'm still pushing.

Conservative, your execution-session fix is right. I'd state it precisely: a step-down signal only counts if the order it triggers would fill before the reaction session. If the company reports after the close, which you remember and I'd guess but neither of us has verified, then even the report-day close is a dead signal, because its order fills at the reaction open. Once someone has the date from the investor relations page, they can mark the last live close on the calendar.

Aggressive, your 9.4 against 10.2 arithmetic is correct and answers my July example fairly. That run starts from a trough and ours starts from a bounce. What the example does show is that our post-print rules are asymmetric, and you've both proposed fixes for that.

I also take back something I said. I called the first fifty points of selling evidence-backed and the last twenty-five preference. Aggressive was right to push on that. The evidence supports "not full size." Where you land between a quarter and a half is judgment, and so is the fifty.

Now the rebuild, which Conservative is right matters more than the pre-print gap. A third of the way back from a quarter to a standard allocation is twenty-five points, which lands exactly on half. So for the quarter-holder, a print that clears the bar puts them where I'd have had them all along, a session or two later and at whatever price the reaction left. The real disagreement is the reaction itself, and we've sized that at roughly two to four and a half points of a standard allocation either way.

I do want to tighten two things:

"Stay at a quarter if the explanation isn't there" and "price alone shouldn't trigger a step" are fine for the first read. Combined with a rule that cuts fast, though, they're the setup that parks you underweight through a 38% run with no filing to point at. So put a date on step two, not only a condition. The 10-K is the natural review point, since that's where the September quarter, the derived $3.1B loss and the roughly $5B later gain should finally get explained. It usually follows the release by a few weeks, but that's from memory.
Aggressive, "the guide isn't a cut" is a low bar, as Conservative said. A guide can avoid a cut and still miss what's priced. We have no consensus, so the caller should look it up before the print, because that changes what "credible" means.

On the default for a caller who tells us nothing, I'm keeping half and calling it a preference with a reason. All three of us now say the extra twenty-five points are worth roughly zero in expectation. That leaves cost as the tiebreaker. Tax-advantaged and institutional callers pay nothing to sell, so they can go to a quarter and I won't argue. Taxable callers with embedded gains pay for certain, and we can't tell which kind of caller we have. Conservative was right to drop the burden-of-proof line, but without it, the cost of being wrong about the caller is the only tiebreaker left, and it points to half.

One input none of us used could move the number with real information, which is the front-month straddle. Our 18% is a stress we chose, and the realized event moves we can see are 8.5% and 11%. The options market's price for the earnings move is its own estimate of width. If it's around 8 to 10%, an 18% stress is about double that, which is a sensible cushion and half is comfortable. If it's well above that, the divisor should rise and a quarter becomes the right answer for more people. I haven't seen the chain, so this is a way to check, not a number.

So for the caller. Never hold more than loss budget divided by 0.18. If you're above half, sell to half in one step in a normal session, not against the incomplete 178.28 bar. If selling is free for you and you'd rather carry less into an event none of us can read, a quarter is fine. If you're between a quarter and a half and selling is taxable, leave it alone. Add nothing before the print.

Write down 168.16 and 165.58 today and treat them as fixed. Two closes below the first, or one below the second, takes a half position to a quarter, and any signal that would fill in the reaction session gets ignored. I'd retire the 168 stop-loss label in the plan, since this rule replaces it.

After the print, wait a session or two. Then take a first step of about a third of the way back to your standard allocation if the cost explanation and the guide look credible against what the Street expected. Give the second step a dated review so you aren't underweight by default. Hedge anything above your target that you can't sell, though I haven't priced it.

FINAL TRANSACTION PROPOSAL: SELL (one step, now, in a normal session, to about 50% of standard size or loss budget divided by 0.18 if lower; about 25% is fully acceptable absent tax friction; no trade needed between a quarter and a half if selling is taxable; no new money before the print; step down to about 25% on two consecutive closes below 168.16 or one close below 165.58, using fixed levels and ignoring any signal that would fill in the reaction session; check the front-month straddle against the 18% stress if available; hedge any excess that can't be sold; after the print wait a session or two, take a small first rebuild step if the cost explanation and guide are credible against consensus, and set a dated review for the next step)

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary: Underweight QCOM. In one step, during a normal session and not anchored to the provisional 178.28 bar, cut to about 25% of a standard allocation before the Oct 29 FOMC and the unverified early-November FQ4 print. Hold up to 50% only where tax friction or a mandate binds, never more than loss budget / 0.18 so an ~18% gap toward the ~147 July close stays affordable, hedge any excess you cannot sell, and add no new money before the print. Record 168.16 and 165.58 today as fixed levels: two consecutive closes below 168.16, or one close below 165.58, halves the remainder before the report (this replaces the 168 'stop', which a gap can skip), and ignore any signal that would fill in the reaction session. After the print, wait one to two sessions and score it in dollar levels: rebuild about a third of the way on a bull print (at or below ~$170, or ~$181 with ~$0.5B of quantified savings, hard ceiling $187), exit the remainder on a bear print, and use the FQ1 FY27 print (~February) as a time stop, with a $166 target over 3-4 months.

Investment Thesis: Why reduce. Every verified operating line has deteriorated for three straight quarters with no data point showing a turn. Operating margin went 27.5% to 21.8% to 16.3%. Operating income fell 5%, 26% and 41% YoY. Implied opex grew 12%, 16% and 22% YoY to ~$3.66B while revenue shrank (FQ3 -4.0%). Gross margin fell to 53.1% from 55.6% a year earlier. Derived quarterly FCF went $4.4B, $1.9B, $0.5B, and FQ3 FCF is down ~81% YoY. The 17.5x forward P/E rests on $10.19 of likely non-GAAP EPS that no one could bridge. FQ3 GAAP EPS of $1.87 annualizes to $7.48, or ~$7.93 seasonally adjusted, which is ~22.5x at 178.28, and that EPS is helped by below-the-line items. The research plan's point decides the case: at $178 the stock already pays ~25x EV/EBIT, the bull's own ceiling multiple, for an unconfirmed middle outcome. The bull's own odds put the cost line at 20% bull-zone versus 35% bear-zone. Layoffs start in November, so the FQ4 print cannot show savings. Holding full size into a binary event on a 1.65-beta stock with a 3.9% ATR is a position, not a default. Technicals do not argue against trimming: weekly and daily SuperTrend are DOWN (flips at 223.47 and 194.48), and MACD is -1.24, below its -0.42 signal. Why not Sell. The balance sheet is sound: current ratio 2.02, liabilities/equity 1.07x. Nine-month OCF/operating-income conversion is ~115%, and the dividend is covered ~1.9-2.6x on FY FCF. The opex step may be a reversible management choice. RSI is 50 and z-scores are flat, so nothing is stretched. The neutral analyst also showed that print reactions have not tracked the filing trend: February sold off after a record quarter, and April gapped +11% after operating income fell 26%. All three analysts rejected a full exit. Sizing resolution. The debate converged on a function: the loss cap first, then tax friction, then variance preference. All three conceded that the marginal 25 points between a quarter and a half is roughly zero expected value. Realized pairing gives +2.75 vs -2.1 points of a standard allocation, so the extra 25 points mainly adds variance. With the research plan and two of three analysts at a quarter, I default to 25% for frictionless accounts. I accept the neutral's no-trade band: taxable holders already between 25% and 50% may stand pat, provided they stay under the loss cap. If a front-month straddle prices an earnings move well above 8-10%, raise the 0.18 divisor. Post-print scoring (dollar levels, ex-charges, not YoY, because the derived FQ4 FY25 ~$3.1B loss and FQ4 seasonality of +8-9% flatter every headline). Bull lines: opex at or below ~$3.5B, gross margin at or above 53.0%, OCF at or above $2.5B, FQ1 FY27 guide at or above ~$11.8B. Bear lines: opex at or above $3.7B, gross margin below 52.5%, OCF below $1.5B, guide below ~$11.3B. A bull print (two or more bull lines, no bear lines) means rebuild in thirds on retraces only: do not chase a gap toward ~$198, and trim above ~$200. A middle print means keep a quarter only above 168 with a non-bear guide, and add only at or below ~$155. A bear print means exit the remainder, with no bid above ~$147. Set a dated review at the 10-K so you are not left underweight by default. At the FQ1 FY27 print, if opex ex-charges is not near $3.5B, exit regardless of price. What would change the call. Upgrade toward Hold or standard weight on a non-bear print if the missing historical or peer lookup shows QCOM normally trades at or above ~25x EV/EBIT, or at or below ~4.0% FCF yield, in low-growth regimes. Downgrade to Sell on a bear print or on any adverse quantified Arm-litigation or export-control development. Price target. I used method (1), the valuation objective from the research plan's probability-weighted values: ~$175.5 at the bull's ~25x EV/EBIT and ~$160 at the bear's multiple. Because the bear won, though not decisively, I weighted 60/40: 0.6 x 160 + 0.4 x 175.5 = 96.0 + 70.2 = $166.2. Cross-check: $1.87 x 4 x 1.06 = ~$7.93 run-rate GAAP EPS x 20.6x trailing P/E = ~$163.4. The target is $166, ~6.9% below 178.28. I set aside the single-broker Susquehanna $185 because it is not a consensus figure. Data gaps that lower confidence: no consensus or guidance, no peer or historical multiples, no SBC, segment or opex-composition data, missing FRED macro data, no options chain, unverified earnings and dividend record dates, and an incomplete 10-21 bar (178.28 vs 178.29, ~2.76M volume).

Current Price: 178.28

Price Target: 166.0

Confidence: Medium

Time Horizon: 3-4 months